293SLAM rinderpest infection, 00hr, biol_rep1 | 13541-145H4 |
251.30 | 128.96 | 0.39 |
293SLAM rinderpest infection, 00hr, biol_rep2 | 13542-145H5 |
241.77 | 114.11 | 0.20 |
293SLAM rinderpest infection, 00hr, biol_rep3 | 13543-145H6 |
254.44 | 125.97 | 0.39 |
293SLAM rinderpest infection, 06hr, biol_rep1 | 13544-145H7 |
227.25 | 104.58 | 0.00 |
293SLAM rinderpest infection, 06hr, biol_rep2 | 13545-145H8 |
237.56 | 108.21 | 0.45 |
293SLAM rinderpest infection, 06hr, biol_rep3 | 13546-145H9 |
219.39 | 127.33 | 0.19 |
293SLAM rinderpest infection, 12hr, biol_rep1 | 13547-145I1 |
287.82 | 149.03 | 0.87 |
293SLAM rinderpest infection, 12hr, biol_rep2 | 13548-145I2 |
214.12 | 139.03 | 0.24 |
293SLAM rinderpest infection, 12hr, biol_rep3 | 13549-145I3 |
220.77 | 118.19 | 0.21 |
293SLAM rinderpest infection, 24hr, biol_rep1 | 13550-145I4 |
209.25 | 117.66 | 0.00 |
293SLAM rinderpest infection, 24hr, biol_rep2 | 13551-145I5 |
172.20 | 109.55 | 0.81 |
293SLAM rinderpest infection, 24hr, biol_rep3 | 13552-145I6 |
191.89 | 110.18 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1 | 13625-146H7 |
162.48 | 98.81 | 0.16 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2 | 13626-146H8 |
142.68 | 101.04 | 0.30 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3 | 13627-146H9 |
153.91 | 110.65 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1 | 13628-146I1 |
138.57 | 93.05 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2 | 13629-146I2 |
124.93 | 84.96 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3 | 13630-146I3 |
117.69 | 73.40 | 0.84 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1 | 13631-146I4 |
140.22 | 82.11 | 0.53 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2 | 13632-146I5 |
152.25 | 96.88 | 0.15 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3 | 13633-146I6 |
145.28 | 96.10 | 0.13 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1 | 13634-146I7 |
151.56 | 113.59 | 0.17 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2 | 13635-146I8 |
141.02 | 106.25 | 0.39 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3 | 13636-146I9 |
131.53 | 96.82 | 0.73 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1 | 13637-147A1 |
158.41 | 97.78 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2 | 13638-147A2 |
128.82 | 79.13 | 0.95 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3 | 13639-147A3 |
147.80 | 85.17 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1 | 13640-147A4 |
183.18 | 116.46 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2 | 13641-147A5 |
139.23 | 91.75 | 0.16 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3 | 13642-147A6 |
169.38 | 119.98 | 0.18 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 13643-147A7 |
149.26 | 108.02 | 0.21 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2 | 13644-147A8 |
157.28 | 100.23 | 0.20 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3 | 13645-147A9 |
136.54 | 92.01 | 0.21 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1 | 13646-147B1 |
190.01 | 154.38 | 0.16 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 13647-147B2 |
160.25 | 121.17 | 0.93 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 13648-147B3 |
158.86 | 92.55 | 0.19 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 13649-147B4 |
169.23 | 116.29 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 13650-147B5 |
148.50 | 106.79 | 0.20 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 13651-147B6 |
172.33 | 120.20 | 0.54 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 13652-147B7 |
169.96 | 118.59 | 0.48 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 13653-147B8 |
157.15 | 106.57 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 13654-147B9 |
196.61 | 133.95 | 0.15 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 13655-147C1 |
194.02 | 129.91 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 13656-147C2 |
182.69 | 117.48 | 0.17 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 13657-147C3 |
201.58 | 144.56 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 13658-147C4 |
195.89 | 133.77 | 0.23 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 13659-147C5 |
181.13 | 118.75 | 0.24 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 13660-147C6 |
179.43 | 112.96 | 0.30 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1 | 13661-147C7 |
180.73 | 136.44 | 0.48 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 13662-147C8 |
207.66 | 138.71 | 0.40 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 13663-147C9 |
260.09 | 158.84 | 0.61 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 13664-147D1 |
276.41 | 153.22 | 0.44 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2 | 13665-147D2 |
1007.44 | 461.74 | 13.99 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3 | 13666-147D3 |
214.69 | 135.56 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1 | 13667-147D4 |
208.44 | 121.95 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2 | 13668-147D5 |
373.33 | 325.51 | 1.68 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 13669-147D6 |
284.27 | 206.66 | 0.92 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1 | 13670-147D7 |
229.47 | 138.39 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2 | 13671-147D8 |
194.63 | 120.12 | 0.32 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3 | 13672-147D9 |
354.25 | 237.32 | 0.63 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2 | 13674-147E2 |
183.31 | 153.70 | 0.71 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3 | 13675-147E3 |
182.82 | 111.60 | 0.56 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 13676-147E4 |
339.95 | 228.49 | 2.39 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2 | 13677-147E5 |
243.61 | 172.60 | 0.68 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 13678-147E6 |
203.73 | 120.55 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1 | 13679-147E7 |
141.99 | 97.62 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2 | 13680-147E8 |
533.41 | 355.61 | 16.16 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 13681-147E9 |
663.39 | 568.62 | 15.79 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 13682-147F1 |
156.01 | 91.65 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2 | 13683-147F2 |
189.42 | 117.52 | 0.99 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 13684-147F3 |
181.55 | 105.08 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1 | 13685-147F4 |
238.46 | 121.88 | 0.33 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 13686-147F5 |
147.56 | 99.30 | 0.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3 | 13687-147F6 |
187.42 | 81.63 | 0.31 |
Adipocyte - breast, donor1 | 11376-118A8 |
113.72 | 79.03 | 0.32 |
Adipocyte - breast, donor2 | 11327-117E4 |
114.87 | 94.65 | 0.16 |
Adipocyte - omental, donor1 | 11473-119C6 |
111.20 | 114.50 | 0.13 |
Adipocyte - omental, donor2 | 11474-119C7 |
89.70 | 61.29 | 0.00 |
Adipocyte - omental, donor3 | 11475-119C8 |
96.79 | 51.91 | 0.00 |
Adipocyte - perirenal, donor1 | 11476-119C9 |
99.53 | 81.66 | 0.64 |
Adipocyte - subcutaneous, donor1 | 11259-116F8 |
72.57 | 31.89 | 0.00 |
Adipocyte - subcutaneous, donor2 | 11336-117F4 |
92.58 | 65.94 | 0.00 |
Adipocyte - subcutaneous, donor3 | 11408-118E4 |
90.02 | 59.95 | 0.35 |
Adipocyte differentiation, day04, donor1 | 13019-139D4 |
131.23 | 168.19 | 0.00 |
Adipocyte differentiation, day04, donor2 | 13022-139D7 |
147.22 | 98.58 | 0.51 |
Adipocyte differentiation, day04, donor3 | 13025-139E1 |
97.29 | 78.61 | 0.56 |
Adipocyte differentiation, day04, donor4 | 13028-139E4 |
185.16 | 131.67 | 0.59 |
Adipocyte differentiation, day08, donor1 | 13020-139D5 |
112.53 | 154.11 | 0.24 |
Adipocyte differentiation, day08, donor2 | 13023-139D8 |
140.40 | 110.70 | 0.97 |
Adipocyte differentiation, day08, donor3 | 13026-139E2 |
109.84 | 105.57 | 0.00 |
Adipocyte differentiation, day08, donor4 | 13029-139E5 |
127.98 | 111.84 | 0.56 |
Adipocyte differentiation, day12, donor1 | 13021-139D6 |
100.65 | 89.83 | 0.00 |
Adipocyte differentiation, day12, donor2 | 13024-139D9 |
107.75 | 95.69 | 0.75 |
Adipocyte differentiation, day12, donor3 | 13027-139E3 |
108.65 | 83.77 | 0.33 |
Adipocyte differentiation, day12, donor4 | 13030-139E6 |
95.60 | 81.60 | 0.00 |
Alveolar Epithelial Cells, donor1 | 11510-119G7 |
111.60 | 75.36 | 0.22 |
Alveolar Epithelial Cells, donor2 | 11590-120G6 |
43.39 | 19.36 | 0.36 |
Alveolar Epithelial Cells, donor3 | 11671-122G6 |
44.33 | 9.58 | 0.00 |
Amniotic Epithelial Cells, donor1 | 11533-120A3 |
124.67 | 79.34 | 0.00 |
Amniotic Epithelial Cells, donor2 | 11613-122A2 |
92.04 | 36.82 | 0.00 |
Amniotic Epithelial Cells, donor3 | 11694-123A2 |
110.33 | 63.48 | 0.00 |
Anulus Pulposus Cell, donor1 | 11248-116E6 |
177.47 | 115.57 | 0.23 |
Anulus Pulposus Cell, donor2 | 11463-119B5 |
126.13 | 69.80 | 0.24 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1) | 12642-134G5 |
120.41 | 83.12 | 0.45 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2) | 12740-135I4 |
123.30 | 75.97 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3) | 12838-137B3 |
94.17 | 59.93 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4) | 12643-134G6 |
113.29 | 87.29 | 0.90 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5) | 12741-135I5 |
126.47 | 78.41 | 1.26 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6) | 12839-137B4 |
99.01 | 62.05 | 0.66 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7) | 12644-134G7 |
98.12 | 76.67 | 0.32 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8) | 12742-135I6 |
130.58 | 82.04 | 0.49 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9) | 12840-137B5 |
103.93 | 64.14 | 0.00 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10) | 12645-134G8 |
125.80 | 96.80 | 0.38 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 12743-135I7 |
111.03 | 71.12 | 1.45 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12) | 12841-137B6 |
99.05 | 52.66 | 1.25 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13) | 12646-134G9 |
93.24 | 91.59 | 0.16 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 12744-135I8 |
122.83 | 80.52 | 0.00 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15) | 12842-137B7 |
79.32 | 76.15 | 0.30 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 12647-134H1 |
115.19 | 82.51 | 0.00 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17) | 12745-135I9 |
119.60 | 92.58 | 0.19 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18) | 12843-137B8 |
126.16 | 88.47 | 0.00 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 12648-134H2 |
98.52 | 68.28 | 0.00 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 12746-136A1 |
109.30 | 96.20 | 0.17 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21) | 12844-137B9 |
104.46 | 73.24 | 0.00 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22) | 12649-134H3 |
113.28 | 95.58 | 0.00 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23) | 12747-136A2 |
112.52 | 86.97 | 0.17 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24) | 12845-137C1 |
104.87 | 33.56 | 0.00 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25) | 12650-134H4 |
131.06 | 82.04 | 0.49 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 12748-136A3 |
124.08 | 90.69 | 0.00 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27) | 12846-137C2 |
111.45 | 70.26 | 0.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28) | 12651-134H5 |
99.19 | 88.36 | 0.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29) | 12749-136A4 |
99.19 | 80.38 | 0.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30) | 12847-137C3 |
101.43 | 59.10 | 0.77 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31) | 12652-134H6 |
100.41 | 75.07 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32) | 12750-136A5 |
95.50 | 76.53 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33) | 12848-137C4 |
97.74 | 72.06 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34) | 12653-134H7 |
92.42 | 63.76 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35) | 12751-136A6 |
127.65 | 93.03 | 0.60 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36) | 12849-137C5 |
129.49 | 80.78 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37) | 12654-134H8 |
125.11 | 85.44 | 0.51 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38) | 12752-136A7 |
113.08 | 100.86 | 0.25 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39) | 12850-137C6 |
87.68 | 61.63 | 0.00 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40) | 12655-134H9 |
104.00 | 61.28 | 0.43 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41) | 12753-136A8 |
109.87 | 94.20 | 0.42 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42) | 12851-137C7 |
109.61 | 59.16 | 0.87 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43) | 12656-134I1 |
126.59 | 79.36 | 0.94 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44) | 12754-136A9 |
101.71 | 85.78 | 0.34 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 12852-137C8 |
94.97 | 46.33 | 0.00 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46) | 12657-134I2 |
139.43 | 95.07 | 0.00 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47) | 12755-136B1 |
100.34 | 88.12 | 0.00 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48) | 12853-137C9 |
109.50 | 75.81 | 0.00 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49) | 12658-134I3 |
109.35 | 81.65 | 0.00 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50) | 12756-136B2 |
113.79 | 98.62 | 0.00 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51) | 12854-137D1 |
99.46 | 68.86 | 0.00 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52) | 12659-134I4 |
88.22 | 73.22 | 0.25 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53) | 12757-136B3 |
119.94 | 90.21 | 0.21 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54) | 12855-137D2 |
115.97 | 73.75 | 0.61 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55) | 12660-134I5 |
120.46 | 105.16 | 0.00 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56) | 12758-136B4 |
105.10 | 93.35 | 0.67 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57) | 12856-137D3 |
83.92 | 54.93 | 0.00 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58) | 12661-134I6 |
106.90 | 63.14 | 2.22 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 12759-136B5 |
113.86 | 91.62 | 0.53 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60) | 12857-137D4 |
99.58 | 79.59 | 0.36 |
Astrocyte - cerebellum, donor1 | 11500-119F6 |
111.03 | 80.32 | 0.12 |
Astrocyte - cerebellum, donor2 | 11580-120F5 |
120.67 | 39.71 | 0.00 |
Astrocyte - cerebellum, donor3 | 11661-122F5 |
78.03 | 30.41 | 0.00 |
Astrocyte - cerebral cortex, donor1 | 11235-116D2 |
260.74 | 177.43 | 1.05 |
Astrocyte - cerebral cortex, donor2 | 11316-117D2 |
364.80 | 173.10 | 0.49 |
Astrocyte - cerebral cortex, donor3 | 11392-118C6 |
323.23 | 202.11 | 0.60 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1 | 10821-111C2 |
502.44 | 327.66 | 1.38 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2 | 10822-111C3 |
569.15 | 375.09 | 1.63 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3 | 10823-111C4 |
556.35 | 358.23 | 1.02 |
Basophils, donor1 | 12241-129G9 |
206.61 | 141.75 | 3.92 |
Basophils, donor2 | 12242-129H1 |
334.82 | 269.15 | 6.49 |
Basophils, donor3 | 12243-129H2 |
195.07 | 155.82 | 2.35 |
Bronchial Epithelial Cell, donor1 | 11511-119G8 |
67.27 | 28.89 | 0.00 |
Bronchial Epithelial Cell, donor2 | 11591-120G7 |
41.60 | 11.89 | 0.00 |
Bronchial Epithelial Cell, donor3 | 11672-122G7 |
164.99 | 14.35 | 0.00 |
Bronchial Epithelial Cell, donor4 | 11453-119A4 |
146.87 | 47.07 | 0.00 |
Bronchial Epithelial Cell, donor5 | 11457-119A8 |
170.10 | 57.19 | 0.21 |
Bronchial Epithelial Cell, donor6 | 11461-119B3 |
111.23 | 49.74 | 0.23 |
Bronchial Epithelial Cell, donor7 | 11769-123I5 |
154.03 | 78.10 | 0.00 |
Burkitt's lymphoma cell line:DAUDI | 10422-106C8 |
350.90 | 268.87 | 1.13 |
Burkitt's lymphoma cell line:RAJI | 10476-106I8 |
316.52 | 253.63 | 0.93 |
CD133+ stem cells - adult bone marrow derived, pool1 | 12224-129F1 |
323.61 | 197.94 | 5.12 |
CD133+ stem cells - cord blood derived, pool1 | 12223-129E9 |
361.97 | 320.60 | 0.00 |
CD14+ Monocytes, donor1 | 11224-116B9 |
198.94 | 107.08 | 6.20 |
CD14+ Monocytes, donor2 | 11305-117B9 |
283.41 | 115.07 | 7.80 |
CD14+ Monocytes, donor3 | 11381-118B4 |
232.71 | 124.92 | 5.93 |
CD14+ monocyte derived endothelial progenitor cells, donor1 | 11229-116C5 |
137.84 | 138.13 | 1.13 |
CD14+ monocyte derived endothelial progenitor cells, donor2 | 11310-117C5 |
148.22 | 142.15 | 0.76 |
CD14+ monocyte derived endothelial progenitor cells, donor3 | 11386-118B9 |
143.99 | 143.66 | 0.66 |
CD14+ monocytes - mock treated, donor1 | 11863-125A9 |
265.83 | 199.19 | 1.01 |
CD14+ monocytes - mock treated, donor2 | 11873-125C1 |
268.25 | 142.42 | 1.51 |
CD14+ monocytes - mock treated, donor3 | 11883-125D2 |
290.90 | 180.04 | 1.18 |
CD14+ monocytes - treated with B-glucan, donor1 | 11869-125B6 |
230.34 | 151.33 | 1.67 |
CD14+ monocytes - treated with B-glucan, donor2 | 11879-125C7 |
230.75 | 114.54 | 2.21 |
CD14+ monocytes - treated with B-glucan, donor3 | 11889-125D8 |
225.37 | 169.09 | 2.73 |
CD14+ monocytes - treated with BCG, donor1 | 11860-125A6 |
230.85 | 128.05 | 0.39 |
CD14+ monocytes - treated with BCG, donor2 | 11870-125B7 |
208.85 | 101.13 | 1.78 |
CD14+ monocytes - treated with BCG, donor3 | 11880-125C8 |
201.31 | 157.56 | 1.31 |
CD14+ monocytes - treated with Candida, donor1 | 11868-125B5 |
246.07 | 125.96 | 1.17 |
CD14+ monocytes - treated with Candida, donor2 | 11878-125C6 |
298.86 | 129.89 | 1.06 |
CD14+ monocytes - treated with Candida, donor3 | 11888-125D7 |
286.21 | 125.36 | 2.22 |
CD14+ monocytes - treated with Cryptococcus, donor1 | 11867-125B4 |
231.45 | 150.24 | 1.78 |
CD14+ monocytes - treated with Cryptococcus, donor2 | 11877-125C5 |
235.07 | 141.48 | 0.80 |
CD14+ monocytes - treated with Cryptococcus, donor3 | 11887-125D6 |
227.15 | 185.09 | 0.62 |
CD14+ monocytes - treated with Group A streptococci, donor1 | 11864-125B1 |
232.22 | 162.44 | 0.92 |
CD14+ monocytes - treated with Group A streptococci, donor2 | 11874-125C2 |
208.11 | 116.04 | 0.00 |
CD14+ monocytes - treated with Group A streptococci, donor3 | 11884-125D3 |
226.52 | 130.94 | 0.87 |
CD14+ monocytes - treated with IFN + N-hexane, donor1 | 11861-125A7 |
282.17 | 165.16 | 1.08 |
CD14+ monocytes - treated with IFN + N-hexane, donor2 | 11871-125B8 |
262.21 | 126.66 | 2.09 |
CD14+ monocytes - treated with IFN + N-hexane, donor3 | 11881-125C9 |
278.16 | 178.01 | 0.84 |
CD14+ monocytes - treated with Salmonella, donor1 | 11866-125B3 |
220.09 | 146.97 | 0.92 |
CD14+ monocytes - treated with Salmonella, donor2 | 11876-125C4 |
266.67 | 131.40 | 1.41 |
CD14+ monocytes - treated with Salmonella, donor3 | 11886-125D5 |
276.84 | 167.15 | 0.88 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1 | 11862-125A8 |
198.26 | 112.30 | 1.57 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2 | 11872-125B9 |
201.82 | 90.69 | 4.09 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3 | 11882-125D1 |
214.69 | 150.45 | 1.51 |
CD14+ monocytes - treated with lipopolysaccharide, donor1 | 11865-125B2 |
226.04 | 153.97 | 1.64 |
CD14+ monocytes - treated with lipopolysaccharide, donor2 | 11875-125C3 |
193.55 | 114.97 | 0.70 |
CD14+ monocytes - treated with lipopolysaccharide, donor3 | 11885-125D4 |
212.27 | 155.43 | 1.39 |
CD14+CD16+ Monocytes, donor1 | 11789-124B7 |
222.54 | 182.65 | 3.92 |
CD14+CD16+ Monocytes, donor2 | 11801-124D1 |
236.77 | 118.27 | 4.16 |
CD14+CD16+ Monocytes, donor3 | 11912-125G4 |
235.46 | 120.65 | 2.82 |
CD14+CD16- Monocytes, donor1 | 11788-124B6 |
291.67 | 219.10 | 4.52 |
CD14+CD16- Monocytes, donor2 | 11799-124C8 |
290.78 | 149.67 | 6.81 |
CD14+CD16- Monocytes, donor3 | 11910-125G2 |
411.38 | 198.22 | 2.68 |
CD14-CD16+ Monocytes, donor1 | 11790-124B8 |
197.51 | 141.11 | 5.61 |
CD14-CD16+ Monocytes, donor2 | 11800-124C9 |
206.83 | 121.20 | 3.51 |
CD14-CD16+ Monocytes, donor3 | 11911-125G3 |
242.76 | 130.54 | 4.21 |
CD19+ B Cells (pluriselect), donor090309, donation1 | 12189-129B2 |
288.59 | 229.65 | 0.00 |
CD19+ B Cells (pluriselect), donor090309, donation2 | 12194-129B7 |
263.06 | 246.78 | 3.39 |
CD19+ B Cells (pluriselect), donor090309, donation3 | 12199-129C3 |
280.65 | 277.54 | 4.14 |
CD19+ B Cells (pluriselect), donor090325, donation1 | 12151-128F9 |
244.13 | 277.71 | 9.06 |
CD19+ B Cells (pluriselect), donor090325, donation2 | 12174-128I5 |
323.78 | 320.03 | 5.90 |
CD19+ B Cells (pluriselect), donor090612, donation1 | 12204-129C8 |
268.14 | 235.85 | 4.91 |
CD19+ B Cells (pluriselect), donor090612, donation2 | 12209-129D4 |
243.93 | 218.83 | 1.57 |
CD19+ B Cells (pluriselect), donor090612, donation3 | 12214-129D9 |
272.89 | 292.66 | 5.27 |
CD19+ B Cells, donor1 | 11544-120B5 |
387.94 | 334.51 | 7.40 |
CD19+ B Cells, donor2 | 11624-122B4 |
322.09 | 280.02 | 8.71 |
CD19+ B Cells, donor3 | 11705-123B4 |
334.70 | 290.27 | 9.09 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep1 | 11931-125I5 |
630.33 | 386.28 | 0.81 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep2 | 11932-125I6 |
449.03 | 248.88 | 0.80 |
CD34+ Progenitors, donor1 | 11545-120B6 |
220.89 | 149.60 | 1.00 |
CD34+ Progenitors, donor2 | 11625-122B5 |
289.33 | 126.97 | 2.25 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1 | 12225-129F2 |
274.68 | 185.62 | 3.76 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2 | 12225-129F2 |
372.27 | 196.17 | 5.41 |
CD4+ T Cells, donor1 | 11225-116C1 |
334.92 | 278.86 | 11.78 |
CD4+ T Cells, donor2 | 11306-117C1 |
378.44 | 191.06 | 20.21 |
CD4+ T Cells, donor3 | 11382-118B5 |
398.32 | 220.82 | 6.40 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1 | 11793-124C2 |
279.23 | 219.25 | 2.30 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2 | 11915-125G7 |
305.00 | 191.58 | 4.72 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 11919-125H2 |
309.31 | 152.64 | 4.31 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1 | 11780-124A7 |
370.74 | 280.66 | 1.42 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2 | 11796-124C5 |
386.98 | 226.15 | 11.94 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3 | 11907-125F8 |
425.21 | 174.70 | 6.59 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1 | 11794-124C3 |
235.13 | 192.06 | 1.73 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2 | 11916-125G8 |
339.77 | 191.66 | 3.05 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3 | 11920-125H3 |
308.71 | 142.34 | 4.51 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1 | 11782-124A9 |
304.84 | 228.63 | 4.48 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2 | 11797-124C6 |
324.93 | 221.51 | 6.29 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3 | 11908-125F9 |
379.70 | 215.15 | 5.72 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1 | 11791-124B9 |
310.75 | 232.75 | 2.53 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2 | 11913-125G5 |
304.17 | 186.78 | 3.95 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3 | 11917-125G9 |
350.83 | 147.68 | 5.01 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 11784-124B2 |
336.38 | 302.93 | 11.97 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2 | 11795-124C4 |
441.62 | 270.12 | 13.40 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3 | 11906-125F7 |
450.10 | 208.01 | 10.76 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1 | 11792-124C1 |
318.57 | 259.60 | 3.52 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2 | 11914-125G6 |
246.08 | 162.25 | 1.52 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3 | 11918-125H1 |
240.62 | 155.09 | 3.99 |
CD4+CD25-CD45RA- memory conventional T cells, donor1 | 11786-124B4 |
314.49 | 228.53 | 5.56 |
CD4+CD25-CD45RA- memory conventional T cells, donor2 | 11798-124C7 |
311.07 | 190.20 | 5.63 |
CD4+CD25-CD45RA- memory conventional T cells, donor3 | 11909-125G1 |
430.15 | 248.85 | 6.54 |
CD8+ T Cells (pluriselect), donor090309, donation1 | 12186-129A8 |
371.15 | 264.76 | 5.94 |
CD8+ T Cells (pluriselect), donor090309, donation2 | 12191-129B4 |
307.42 | 215.10 | 3.69 |
CD8+ T Cells (pluriselect), donor090309, donation3 | 12196-129B9 |
350.35 | 234.50 | 6.98 |
CD8+ T Cells (pluriselect), donor090325, donation1 | 12148-128F6 |
300.47 | 224.04 | 2.22 |
CD8+ T Cells (pluriselect), donor090325, donation2 | 12171-128I2 |
355.08 | 287.84 | 0.98 |
CD8+ T Cells (pluriselect), donor090612, donation1 | 12201-129C5 |
351.12 | 298.76 | 9.24 |
CD8+ T Cells (pluriselect), donor090612, donation2 | 12206-129D1 |
333.05 | 261.43 | 3.94 |
CD8+ T Cells (pluriselect), donor090612, donation3 | 12211-129D6 |
360.10 | 260.38 | 1.38 |
CD8+ T Cells, donor1 | 11226-116C2 |
280.25 | 202.33 | 8.51 |
CD8+ T Cells, donor2 | 11307-117C2 |
320.99 | 136.28 | 13.89 |
CD8+ T Cells, donor3 | 11383-118B6 |
334.80 | 250.22 | 16.92 |
COBL-a rinderpest infection, 00hr, biol_rep1 | 13553-145I7 |
222.74 | 82.81 | 0.92 |
COBL-a rinderpest infection, 00hr, biol_rep2 | 13554-145I8 |
209.69 | 91.30 | 0.48 |
COBL-a rinderpest infection, 00hr, biol_rep3 | 13555-145I9 |
215.59 | 101.23 | 0.55 |
COBL-a rinderpest infection, 06hr, biol_rep1 | 13556-146A1 |
200.24 | 135.70 | 0.90 |
COBL-a rinderpest infection, 06hr, biol_rep2 | 13557-146A2 |
199.43 | 77.99 | 0.72 |
COBL-a rinderpest infection, 06hr, biol_rep3 | 13558-146A3 |
235.12 | 92.32 | 0.45 |
COBL-a rinderpest infection, 12hr, biol_rep1 | 13559-146A4 |
216.20 | 102.56 | 0.65 |
COBL-a rinderpest infection, 12hr, biol_rep2 | 13560-146A5 |
232.94 | 97.39 | 0.26 |
COBL-a rinderpest infection, 12hr, biol_rep3 | 13561-146A6 |
241.08 | 88.88 | 0.23 |
COBL-a rinderpest infection, 24hr, biol_rep1 | 13562-146A7 |
281.05 | 102.03 | 0.00 |
COBL-a rinderpest infection, 24hr, biol_rep2 | 13563-146A8 |
260.00 | 111.26 | 0.00 |
COBL-a rinderpest infection, 24hr, biol_rep3 | 13564-146A9 |
268.30 | 126.29 | 0.27 |
COBL-a rinderpest infection, 48hr, biol_rep1 | 13565-146B1 |
183.86 | 70.04 | 1.31 |
COBL-a rinderpest infection, 48hr, biol_rep2 | 13566-146B2 |
205.85 | 73.32 | 0.46 |
COBL-a rinderpest infection, 48hr, biol_rep3 | 13567-146B3 |
184.23 | 72.35 | 0.75 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep1 | 13568-146B4 |
217.89 | 96.16 | 0.00 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 13569-146B5 |
185.29 | 85.45 | 0.29 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 13570-146B6 |
205.06 | 92.39 | 0.71 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep1 | 13571-146B7 |
238.31 | 115.99 | 0.00 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep2 | 13572-146B8 |
230.36 | 111.65 | 0.31 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep3 | 13573-146B9 |
216.07 | 90.08 | 0.00 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep1 | 13574-146C1 |
232.54 | 106.33 | 0.76 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep2 | 13575-146C2 |
245.53 | 101.28 | 0.00 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep3 | 13576-146C3 |
231.46 | 84.72 | 0.76 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 13577-146C4 |
231.25 | 113.22 | 0.80 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep2 | 13578-146C5 |
232.91 | 114.01 | 4.20 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep3 | 13579-146C6 |
243.43 | 122.21 | 2.00 |
Cardiac Myocyte, donor1 | 11525-119I4 |
279.64 | 69.45 | 0.00 |
Cardiac Myocyte, donor2 | 11605-120I3 |
184.79 | 99.81 | 0.49 |
Cardiac Myocyte, donor3 | 11686-122I3 |
114.49 | 112.91 | 0.42 |
Chondrocyte - de diff, donor1 | 11261-116G1 |
133.81 | 93.25 | 0.00 |
Chondrocyte - de diff, donor2 | 11338-117F6 |
89.91 | 86.71 | 0.36 |
Chondrocyte - de diff, donor3 | 11410-118E6 |
127.09 | 84.08 | 0.34 |
Chondrocyte - re diff, donor2 | 11339-117F7 |
265.89 | 190.69 | 0.90 |
Chondrocyte - re diff, donor3 | 11411-118E7 |
118.49 | 78.45 | 0.00 |
Ciliary Epithelial Cells, donor1 | 11242-116D9 |
263.60 | 187.51 | 1.84 |
Ciliary Epithelial Cells, donor2 | 11323-117D9 |
244.33 | 136.38 | 0.43 |
Ciliary Epithelial Cells, donor3 | 11399-118D4 |
253.37 | 143.81 | 0.18 |
Clontech Human Universal Reference Total RNA, pool1 | 10000-101A1 |
170.01 | 149.20 | 1.56 |
Corneal Epithelial Cells, donor1 | 11526-119I5 |
52.48 | 14.49 | 0.22 |
Corneal Epithelial Cells, donor2 | 11606-120I4 |
104.66 | 27.30 | 0.00 |
Corneal Epithelial Cells, donor3 | 11687-122I4 |
130.88 | 32.21 | 0.00 |
Dendritic Cells - monocyte immature derived, donor1, rep2 | 11227-116C3 |
133.89 | 82.71 | 1.16 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1 | 11227-116C3 |
132.16 | 94.62 | 0.95 |
Dendritic Cells - monocyte immature derived, donor2 | 11308-117C3 |
117.32 | 100.07 | 0.00 |
Dendritic Cells - monocyte immature derived, donor3 | 11384-118B7 |
156.69 | 99.89 | 0.22 |
Dendritic Cells - plasmacytoid, donor1 | 11228-116C4 |
265.11 | 294.49 | 5.47 |
Dendritic Cells - plasmacytoid, donor2 | 11309-117C4 |
255.93 | 268.33 | 4.57 |
Dendritic Cells - plasmacytoid, donor3 | 11385-118B8 |
256.97 | 206.64 | 0.00 |
Endothelial Cells - Aortic, donor0 | 11207-116A1 |
168.94 | 123.58 | 0.33 |
Endothelial Cells - Aortic, donor1 | 11263-116G3 |
136.72 | 103.27 | 0.00 |
Endothelial Cells - Aortic, donor2 | 11340-117F8 |
130.37 | 103.22 | 0.28 |
Endothelial Cells - Aortic, donor3 | 11412-118E8 |
210.35 | 113.63 | 0.00 |
Endothelial Cells - Artery, donor1 | 11264-116G4 |
137.87 | 95.41 | 0.00 |
Endothelial Cells - Artery, donor2 | 11341-117F9 |
212.46 | 129.17 | 0.47 |
Endothelial Cells - Artery, donor3 | 11413-118E9 |
203.71 | 157.25 | 0.00 |
Endothelial Cells - Lymphatic, donor1 | 11236-116D3 |
131.44 | 117.70 | 0.22 |
Endothelial Cells - Lymphatic, donor2 | 11317-117D3 |
138.44 | 119.88 | 0.30 |
Endothelial Cells - Lymphatic, donor3 | 11393-118C7 |
116.71 | 149.69 | 0.28 |
Endothelial Cells - Microvascular, donor1 | 11265-116G5 |
114.10 | 58.24 | 0.00 |
Endothelial Cells - Microvascular, donor2 | 11342-117G1 |
119.75 | 86.43 | 0.52 |
Endothelial Cells - Microvascular, donor3 | 11414-118F1 |
114.85 | 74.72 | 0.00 |
Endothelial Cells - Thoracic, donor1 | 11266-116G6 |
205.26 | 160.85 | 0.00 |
Endothelial Cells - Thoracic, donor2 | 11343-117G2 |
118.98 | 92.77 | 0.00 |
Endothelial Cells - Umbilical vein, donor1 | 11243-116E1 |
325.90 | 245.39 | 1.37 |
Endothelial Cells - Umbilical vein, donor2 | 11324-117E1 |
309.60 | 142.52 | 0.43 |
Endothelial Cells - Umbilical vein, donor3 | 11400-118D5 |
368.09 | 160.11 | 0.61 |
Endothelial Cells - Vein, donor1 | 11267-116G7 |
143.33 | 134.23 | 0.00 |
Endothelial Cells - Vein, donor2 | 11344-117G3 |
123.63 | 117.35 | 0.00 |
Endothelial Cells - Vein, donor3 | 11416-118F3 |
206.46 | 119.33 | 0.16 |
Eosinophils, donor1 | 12244-129H3 |
487.90 | 243.95 | 0.00 |
Eosinophils, donor2 | 12245-129H4 |
646.90 | 254.14 | 3.30 |
Eosinophils, donor3 | 12246-129H5 |
492.22 | 253.24 | 3.57 |
Esophageal Epithelial Cells, donor1 | 11507-119G4 |
53.26 | 27.85 | 0.00 |
Esophageal Epithelial Cells, donor2 | 11587-120G3 |
37.44 | 24.96 | 0.00 |
Esophageal Epithelial Cells, donor3 | 11668-122G3 |
211.49 | 16.27 | 0.00 |
Ewing's sarcoma cell line:Hs 863.T | 10705-109H3 |
137.11 | 117.41 | 0.00 |
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 14331-155F2 |
56.93 | 36.68 | 0.00 |
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 14310-155C8 |
125.78 | 61.86 | 0.00 |
Fibroblast - Aortic Adventitial, donor1 | 11245-116E3 |
169.79 | 113.64 | 0.49 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction) | 14332-155F3 |
183.14 | 172.23 | 2.18 |
Fibroblast - Aortic Adventitial, donor2 | 11326-117E3 |
138.80 | 80.89 | 0.00 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction) | 14311-155C9 |
174.43 | 171.53 | 0.26 |
Fibroblast - Aortic Adventitial, donor3 | 11401-118D6 |
214.27 | 132.55 | 1.00 |
Fibroblast - Cardiac, donor1 | 11268-116G8 |
166.03 | 140.62 | 0.00 |
Fibroblast - Cardiac, donor2 | 11345-117G4 |
103.08 | 78.07 | 0.00 |
Fibroblast - Cardiac, donor3 | 11417-118F4 |
88.32 | 63.88 | 0.16 |
Fibroblast - Cardiac, donor4 | 11452-119A3 |
153.37 | 146.10 | 0.00 |
Fibroblast - Cardiac, donor5 | 11456-119A7 |
237.44 | 106.73 | 0.63 |
Fibroblast - Cardiac, donor6 | 11460-119B2 |
224.81 | 141.13 | 0.30 |
Fibroblast - Choroid Plexus, donor1 | 11492-119E7 |
99.02 | 74.10 | 0.13 |
Fibroblast - Choroid Plexus, donor2 | 11572-120E6 |
148.41 | 93.62 | 0.00 |
Fibroblast - Choroid Plexus, donor3 | 11653-122E6 |
210.93 | 70.31 | 0.00 |
Fibroblast - Conjunctival, donor1 | 11531-120A1 |
180.82 | 77.96 | 0.00 |
Fibroblast - Conjunctival, donor3 | 11692-122I9 |
155.53 | 137.55 | 0.68 |
Fibroblast - Dermal, donor1 | 11269-116G9 |
169.75 | 76.77 | 0.00 |
Fibroblast - Dermal, donor2 | 11346-117G5 |
156.60 | 86.32 | 0.00 |
Fibroblast - Dermal, donor3 | 11418-118F5 |
215.18 | 90.54 | 0.36 |
Fibroblast - Dermal, donor4 | 11450-119A1 |
320.82 | 124.46 | 0.34 |
Fibroblast - Dermal, donor5 | 11454-119A5 |
433.17 | 108.34 | 0.17 |
Fibroblast - Dermal, donor6 | 11458-119A9 |
449.43 | 142.77 | 0.49 |
Fibroblast - Gingival, donor1 | 11237-116D4 |
195.94 | 110.57 | 0.00 |
Fibroblast - Gingival, donor10 (periodontitis) | 11928-125I2 |
229.51 | 144.89 | 0.79 |
Fibroblast - Gingival, donor2 | 11318-117D4 |
307.19 | 128.09 | 0.40 |
Fibroblast - Gingival, donor3 | 11394-118C8 |
242.01 | 116.99 | 0.19 |
Fibroblast - Gingival, donor4 (GFH2) | 11222-116B7 |
131.94 | 100.77 | 1.04 |
Fibroblast - Gingival, donor5 (GFH3) | 11303-117B7 |
138.85 | 83.52 | 0.70 |
Fibroblast - Gingival, donor6 (aggressive periodontitis) | 11921-125H4 |
336.74 | 137.66 | 0.16 |
Fibroblast - Gingival, donor6 (control) | 11922-125H5 |
288.30 | 126.84 | 0.54 |
Fibroblast - Gingival, donor7 (aggressive periodontitis) | 11923-125H6 |
117.86 | 55.05 | 0.00 |
Fibroblast - Gingival, donor7 (control) | 11924-125H7 |
299.80 | 123.87 | 0.15 |
Fibroblast - Gingival, donor8 (chronic periodontitis) | 11925-125H8 |
336.25 | 172.35 | 0.68 |
Fibroblast - Gingival, donor8 (control) | 11926-125H9 |
357.27 | 169.26 | 0.22 |
Fibroblast - Gingival, donor9 (control) | 11927-125I1 |
173.59 | 126.20 | 0.15 |
Fibroblast - Lung, donor1 | 11270-116H1 |
123.70 | 61.17 | 0.00 |
Fibroblast - Lung, donor2 | 11347-117G6 |
280.52 | 143.25 | 0.00 |
Fibroblast - Lung, donor3 | 11419-118F6 |
247.76 | 105.94 | 0.00 |
Fibroblast - Lymphatic, donor1 | 11506-119G3 |
108.29 | 59.98 | 0.00 |
Fibroblast - Lymphatic, donor2 | 11586-120G2 |
102.10 | 19.58 | 0.00 |
Fibroblast - Lymphatic, donor3 | 11667-122G2 |
41.70 | 16.23 | 0.00 |
Fibroblast - Mammary, donor1 | 11540-120B1 |
205.83 | 119.76 | 0.00 |
Fibroblast - Mammary, donor2 | 11620-122A9 |
115.83 | 27.96 | 0.00 |
Fibroblast - Mammary, donor3 | 11701-123A9 |
113.17 | 65.52 | 0.00 |
Fibroblast - Periodontal Ligament, donor1 | 11238-116D5 |
281.07 | 158.28 | 0.39 |
Fibroblast - Periodontal Ligament, donor2 | 11319-117D5 |
416.21 | 158.51 | 0.61 |
Fibroblast - Periodontal Ligament, donor3 | 11395-118C9 |
246.32 | 137.08 | 0.00 |
Fibroblast - Periodontal Ligament, donor4 (PL29) | 11223-116B8 |
230.88 | 138.91 | 0.38 |
Fibroblast - Periodontal Ligament, donor5 (PL30) | 11304-117B8 |
161.18 | 83.43 | 0.81 |
Fibroblast - Periodontal Ligament, donor6 (PLH3) | 11380-118B3 |
146.71 | 90.11 | 0.23 |
Fibroblast - Pulmonary Artery, donor1 | 11250-116E8 |
178.40 | 115.84 | 0.11 |
Fibroblast - Villous Mesenchymal, donor1 | 11535-120A5 |
144.87 | 77.62 | 0.00 |
Fibroblast - Villous Mesenchymal, donor2 | 11615-122A4 |
160.37 | 39.42 | 0.00 |
Fibroblast - Villous Mesenchymal, donor3 | 11696-123A4 |
175.54 | 87.77 | 0.00 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 14329-155E9 |
327.04 | 237.14 | 1.98 |
Fibroblast - skin dystrophia myotonica, donor1 | 11556-120C8 |
121.31 | 103.37 | 0.71 |
Fibroblast - skin dystrophia myotonica, donor2 | 11557-120C9 |
145.84 | 123.77 | 0.39 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction) | 14308-155C6 |
245.80 | 206.69 | 0.90 |
Fibroblast - skin dystrophia myotonica, donor3 | 11560-120D3 |
176.61 | 141.31 | 0.11 |
Fibroblast - skin normal, donor1 (nuclear fraction) | 14323-155E3 |
314.32 | 199.68 | 1.01 |
Fibroblast - skin normal, donor1 | 11553-120C5 |
128.47 | 91.72 | 0.00 |
Fibroblast - skin normal, donor2 (nuclear fraction) | 14302-155B9 |
262.46 | 292.14 | 3.21 |
Fibroblast - skin normal, donor2 | 11561-120D4 |
157.73 | 120.96 | 0.40 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction) | 14326-155E6 |
415.27 | 299.22 | 1.21 |
Fibroblast - skin spinal muscular atrophy, donor1 | 11555-120C7 |
141.50 | 116.23 | 0.41 |
Fibroblast - skin spinal muscular atrophy, donor2 | 11558-120D1 |
128.73 | 158.98 | 0.34 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 14305-155C3 |
213.15 | 189.18 | 0.99 |
Fibroblast - skin spinal muscular atrophy, donor3 | 11559-120D2 |
154.88 | 105.78 | 0.43 |
Fibroblast - skin walker warburg, donor1 | 11554-120C6 |
230.08 | 176.95 | 0.17 |
Fibroblast - skin, normal donor1 (cytoplasmic fraction) | 14322-155E2 |
160.11 | 77.31 | 0.00 |
Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 14301-155B8 |
1418.23 | 775.59 | 0.00 |
Fingernail (including nail plate, eponychium and hyponychium), donor2 | 10301-104H4 |
323.34 | 95.87 | 0.00 |
Gingival epithelial cells, donor1 (GEA11) | 11221-116B6 |
131.75 | 77.49 | 0.00 |
Gingival epithelial cells, donor2 (GEA14) | 11302-117B6 |
138.19 | 122.05 | 0.00 |
Gingival epithelial cells, donor3 (GEA15) | 11379-118B2 |
158.16 | 117.79 | 0.00 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1 | 13523-145F4 |
499.91 | 147.75 | 2.30 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2 | 13524-145F5 |
509.18 | 179.94 | 1.28 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3 | 13525-145F6 |
795.89 | 308.66 | 8.56 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1 | 13526-145F7 |
657.96 | 255.90 | 3.86 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2 | 13527-145F8 |
391.35 | 202.07 | 5.25 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3 | 13528-145F9 |
553.58 | 200.51 | 3.17 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1 | 13529-145G1 |
576.25 | 259.31 | 6.34 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2 | 13530-145G2 |
431.49 | 175.47 | 2.94 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3 | 13531-145G3 |
642.55 | 247.65 | 4.86 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0) | 12627-134E8 |
419.16 | 194.60 | 0.28 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0) | 12725-135G7 |
335.19 | 149.37 | 0.25 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0) | 12823-136I6 |
351.36 | 172.73 | 1.07 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1) | 12628-134E9 |
276.78 | 158.21 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 12726-135G8 |
335.55 | 168.33 | 0.14 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1) | 12824-136I7 |
308.61 | 158.37 | 0.81 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3) | 12629-134F1 |
240.27 | 142.16 | 0.68 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3) | 12727-135G9 |
235.80 | 132.66 | 0.37 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3) | 12825-136I8 |
260.54 | 126.99 | 0.87 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 12630-134F2 |
224.86 | 150.69 | 0.30 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6) | 12728-135H1 |
290.73 | 175.49 | 0.64 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6) | 12826-136I9 |
227.66 | 139.64 | 0.45 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9) | 12631-134F3 |
298.82 | 180.26 | 1.01 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9) | 12729-135H2 |
330.46 | 212.90 | 0.68 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9) | 12827-137A1 |
244.29 | 176.81 | 0.62 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
222.89 | 168.36 | 0.52 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
208.86 | 156.60 | 0.17 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12) | 12730-135H3 |
297.99 | 185.23 | 0.11 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
222.05 | 167.97 | 0.83 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
217.04 | 159.67 | 0.41 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15) | 12633-134F5 |
240.55 | 172.06 | 0.62 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15) | 12731-135H4 |
302.07 | 173.75 | 0.35 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15) | 12829-137A3 |
235.31 | 151.92 | 0.83 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18) | 12634-134F6 |
215.36 | 135.34 | 0.66 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18) | 12732-135H5 |
261.97 | 173.05 | 0.12 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18) | 12830-137A4 |
256.43 | 160.80 | 0.65 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21) | 12635-134F7 |
207.18 | 131.49 | 0.32 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21) | 12733-135H6 |
232.15 | 130.76 | 0.19 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21) | 12831-137A5 |
201.67 | 140.93 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24) | 12636-134F8 |
223.50 | 156.30 | 0.91 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24) | 12734-135H7 |
228.83 | 144.68 | 0.42 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24) | 12832-137A6 |
180.91 | 135.03 | 0.66 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27) | 12637-134F9 |
225.28 | 144.48 | 0.84 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27) | 12735-135H8 |
207.30 | 125.36 | 0.09 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27) | 12833-137A7 |
207.77 | 124.88 | 1.07 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30) | 12638-134G1 |
201.81 | 137.09 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30) | 12736-135H9 |
175.78 | 117.88 | 0.26 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30) | 12834-137A8 |
194.90 | 122.52 | 0.27 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34) | 12639-134G2 |
195.23 | 140.66 | 0.37 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34) | 12737-135I1 |
184.44 | 127.42 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34) | 12835-137A9 |
196.37 | 119.01 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41) | 12640-134G3 |
192.20 | 115.56 | 0.66 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41) | 12738-135I2 |
162.01 | 107.54 | 0.00 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 12836-137B1 |
182.23 | 135.21 | 0.00 |
H9 Embryonic Stem cells, biol_rep1 (H9ES-1) | 12626-134E7 |
385.38 | 175.97 | 0.60 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2) | 12724-135G6 |
379.34 | 168.56 | 0.62 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3) | 12822-136I5 |
553.40 | 252.25 | 1.02 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1) | 13364-143F7 |
295.72 | 151.15 | 0.94 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2) | 13365-143F8 |
263.62 | 147.78 | 0.57 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3) | 13366-143F9 |
450.60 | 149.43 | 0.92 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1 | 13328-143B7 |
353.90 | 146.01 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2 | 13340-143D1 |
499.76 | 215.84 | 1.16 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 13352-143E4 |
545.52 | 184.51 | 3.21 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1 | 13329-143B8 |
344.29 | 170.41 | 1.74 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2 | 13341-143D2 |
379.51 | 221.33 | 0.65 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3 | 13353-143E5 |
413.86 | 207.14 | 2.06 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1 | 13330-143B9 |
319.90 | 199.94 | 3.33 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2 | 13342-143D3 |
397.66 | 211.69 | 0.28 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3 | 13354-143E6 |
413.13 | 199.70 | 0.65 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1 | 13331-143C1 |
370.77 | 187.90 | 5.03 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2 | 13343-143D4 |
423.99 | 217.24 | 1.91 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3 | 13355-143E7 |
436.81 | 225.54 | 1.02 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1 | 13332-143C2 |
334.10 | 181.67 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2 | 13344-143D5 |
496.53 | 218.77 | 0.57 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3 | 13356-143E8 |
333.28 | 179.96 | 0.59 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1 | 13333-143C3 |
332.05 | 167.72 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2 | 13345-143D6 |
454.39 | 272.13 | 0.83 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3 | 13357-143E9 |
458.19 | 260.05 | 0.46 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1 | 13334-143C4 |
273.96 | 147.52 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2 | 13346-143D7 |
339.05 | 212.58 | 1.54 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3 | 13358-143F1 |
331.19 | 174.72 | 0.33 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1 | 13335-143C5 |
297.63 | 146.48 | 0.67 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2 | 13347-143D8 |
339.04 | 189.94 | 0.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3 | 13359-143F2 |
382.74 | 208.48 | 2.40 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1 | 13336-143C6 |
248.48 | 121.75 | 4.97 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2 | 13348-143D9 |
367.57 | 192.51 | 3.30 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3 | 13360-143F3 |
336.15 | 158.72 | 1.21 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1 | 13337-143C7 |
347.43 | 201.94 | 1.53 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2 | 13349-143E1 |
345.79 | 183.47 | 1.20 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3 | 13361-143F4 |
348.31 | 221.02 | 1.97 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1 | 13338-143C8 |
383.64 | 147.56 | 3.54 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2 | 13350-143E2 |
281.80 | 151.11 | 0.58 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3 | 13362-143F5 |
281.76 | 142.20 | 2.19 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1 | 13339-143C9 |
352.64 | 178.86 | 2.54 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2 | 13351-143E3 |
262.05 | 160.57 | 1.79 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3 | 13363-143F6 |
315.90 | 186.34 | 1.46 |
Hair Follicle Dermal Papilla Cells, donor1 | 11271-116H2 |
127.83 | 111.85 | 0.00 |
Hair Follicle Dermal Papilla Cells, donor2 | 11348-117G7 |
122.67 | 65.28 | 0.83 |
Hair Follicle Dermal Papilla Cells, donor3 | 11420-118F7 |
148.43 | 91.08 | 0.00 |
Hair Follicle Outer Root Sheath Cells, donor1 | 11504-119G1 |
112.28 | 88.49 | 0.63 |
Hair Follicle Outer Root Sheath Cells, donor2 | 11584-120F9 |
89.40 | 53.05 | 0.00 |
Hep-2 cells mock treated, biol_rep1 | 11898-125E8 |
242.99 | 168.73 | 0.12 |
Hep-2 cells mock treated, biol_rep2 | 11899-125E9 |
286.29 | 169.14 | 0.17 |
Hep-2 cells mock treated, biol_rep3 | 11900-125F1 |
264.13 | 144.92 | 0.00 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1 | 11890-125D9 |
250.32 | 159.04 | 0.00 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2 | 11891-125E1 |
256.18 | 165.05 | 0.43 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3 | 11892-125E2 |
253.60 | 142.73 | 0.65 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1 | 11894-125E4 |
258.17 | 151.56 | 0.25 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2 | 11895-125E5 |
264.70 | 162.97 | 0.00 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3 | 11896-125E6 |
237.08 | 145.13 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor1 | 11521-119H9 |
140.47 | 87.86 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor2 | 11601-120H8 |
76.17 | 33.76 | 0.00 |
Hepatic Sinusoidal Endothelial Cells, donor3 | 11682-122H8 |
280.24 | 126.90 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor1 | 11524-119I3 |
81.83 | 64.20 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor2 | 11604-120I2 |
74.83 | 34.15 | 0.00 |
Hepatic Stellate Cells (lipocyte), donor3 | 11685-122I2 |
202.81 | 111.20 | 0.17 |
Hepatocyte, donor1 | 11523-119I2 |
185.22 | 181.59 | 0.00 |
Hepatocyte, donor2 | 11603-120I1 |
173.45 | 196.08 | 0.00 |
Hepatocyte, donor3 | 11684-122I1 |
180.99 | 157.68 | 0.61 |
Hodgkin's lymphoma cell line:HD-Mar2 | 10435-106E3 |
409.23 | 204.94 | 3.26 |
Intestinal epithelial cells (polarized), donor1 | 11246-116E4 |
178.98 | 131.79 | 0.17 |
Iris Pigment Epithelial Cells, donor1 | 11530-119I9 |
145.85 | 96.73 | 0.14 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1 | 13079-140B1 |
156.01 | 95.52 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 13145-140I4 |
100.13 | 46.73 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3 | 13211-141G7 |
270.83 | 54.17 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1 | 13080-140B2 |
153.67 | 77.53 | 1.38 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2 | 13146-140I5 |
100.11 | 37.54 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3 | 13212-141G8 |
237.37 | 71.21 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1 | 13081-140B3 |
166.59 | 84.58 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2 | 13147-140I6 |
95.99 | 82.27 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3 | 13213-141G9 |
206.29 | 82.84 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1 | 13082-140B4 |
126.72 | 71.69 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2 | 13148-140I7 |
116.18 | 61.72 | 0.00 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3 | 13214-141H1 |
157.49 | 86.03 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1 | 13083-140B5 |
146.34 | 70.95 | 1.11 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2 | 13149-140I8 |
146.67 | 68.10 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3 | 13215-141H2 |
153.06 | 77.47 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 13084-140B6 |
117.54 | 64.96 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 13150-140I9 |
160.98 | 58.54 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3 | 13216-141H3 |
149.88 | 68.48 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1 | 13085-140B7 |
162.60 | 75.67 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2 | 13151-141A1 |
167.27 | 35.84 | 0.00 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3 | 13217-141H4 |
149.12 | 75.78 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1 | 13086-140B8 |
91.10 | 55.00 | 0.42 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 13152-141A2 |
201.21 | 86.23 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3 | 13218-141H5 |
147.07 | 69.92 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1 | 13087-140B9 |
156.03 | 56.32 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2 | 13153-141A3 |
196.05 | 75.40 | 0.00 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3 | 13219-141H6 |
154.36 | 67.50 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 13088-140C1 |
129.70 | 87.98 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2 | 13154-141A4 |
206.39 | 88.45 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3 | 13220-141H7 |
146.35 | 79.63 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1 | 13089-140C2 |
161.35 | 60.98 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2 | 13155-141A5 |
147.87 | 65.72 | 0.00 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 13221-141H8 |
135.19 | 78.43 | 0.00 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1 | 13090-140C3 |
136.70 | 85.67 | 0.00 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2 | 13156-141A6 |
158.04 | 47.41 | 0.00 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 13222-141H9 |
163.52 | 72.12 | 0.71 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1 | 13091-140C4 |
146.01 | 79.64 | 0.00 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2 | 13157-141A7 |
271.03 | 62.55 | 0.00 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3 | 13223-141I1 |
147.54 | 74.39 | 0.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1 | 13092-140C5 |
136.97 | 64.97 | 0.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 13158-141A8 |
113.15 | 72.29 | 0.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3 | 13224-141I2 |
146.03 | 64.67 | 0.00 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1 | 13093-140C6 |
126.15 | 53.11 | 0.00 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2 | 13159-141A9 |
132.92 | 64.84 | 0.00 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3 | 13225-141I3 |
103.76 | 60.16 | 0.00 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep1 | 13094-140C7 |
85.49 | 42.75 | 0.00 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 13160-141B1 |
90.60 | 73.18 | 0.00 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 13226-141I4 |
113.08 | 64.01 | 0.00 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 13095-140C8 |
112.22 | 73.43 | 0.00 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep2 | 13161-141B2 |
96.89 | 39.89 | 0.00 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep3 | 13227-141I5 |
114.13 | 43.26 | 0.00 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep1 | 13096-140C9 |
114.96 | 66.56 | 0.00 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep2 | 13162-141B3 |
62.09 | 31.04 | 0.00 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep3 | 13228-141I6 |
64.50 | 44.41 | 0.00 |
Keratinocyte - epidermal, donor1 | 11272-116H3 |
129.99 | 85.92 | 0.08 |
Keratinocyte - epidermal, donor2 | 11349-117G8 |
63.25 | 40.99 | 0.00 |
Keratinocyte - epidermal, donor3 | 11421-118F8 |
260.78 | 138.20 | 0.28 |
Keratinocyte - oral, donor1 | 11251-116E9 |
289.13 | 143.71 | 0.91 |
Keratocytes, donor1 | 11527-119I6 |
190.48 | 98.34 | 0.00 |
Keratocytes, donor2 | 11607-120I5 |
141.79 | 36.33 | 0.00 |
Keratocytes, donor3 | 11688-122I5 |
242.85 | 155.51 | 0.00 |
Krukenberg tumor cell line:HSKTC | 10687-109F3 |
224.19 | 173.64 | 0.00 |
Lens Epithelial Cells, donor1 | 11529-119I8 |
171.52 | 106.80 | 0.00 |
Lens Epithelial Cells, donor2 | 11609-120I7 |
197.22 | 180.26 | 0.35 |
Lens Epithelial Cells, donor3 | 11690-122I7 |
132.29 | 87.89 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1) | 12260-130A1 |
137.43 | 139.68 | 0.36 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1) | 12382-131E6 |
132.56 | 75.07 | 0.84 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ) | 12504-133A2 |
185.27 | 104.52 | 0.63 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2) | 12261-130A2 |
136.58 | 95.18 | 0.54 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2) | 12383-131E7 |
138.67 | 78.16 | 0.32 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2) | 12505-133A3 |
136.71 | 67.38 | 0.32 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3) | 12262-130A3 |
140.35 | 97.26 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3) | 12384-131E8 |
95.31 | 52.08 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3) | 12506-133A4 |
136.67 | 72.77 | 0.56 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4) | 12263-130A4 |
122.62 | 85.04 | 0.40 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4) | 12385-131E9 |
138.82 | 81.63 | 0.78 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4) | 12507-133A5 |
85.35 | 41.10 | 0.19 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5) | 12264-130A5 |
157.14 | 106.62 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5) | 12386-131F1 |
116.64 | 76.33 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5) | 12508-133A6 |
125.26 | 71.15 | 0.27 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6) | 12265-130A6 |
135.19 | 91.46 | 0.92 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6) | 12387-131F2 |
96.95 | 57.36 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6) | 12509-133A7 |
129.01 | 74.11 | 0.55 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7) | 12266-130A7 |
142.50 | 91.16 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7) | 12388-131F3 |
92.84 | 62.97 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7) | 12510-133A8 |
114.76 | 53.77 | 0.25 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8) | 12267-130A8 |
129.97 | 91.17 | 0.48 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8) | 12389-131F4 |
129.80 | 84.56 | 0.54 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8) | 12511-133A9 |
152.59 | 82.50 | 0.91 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 12268-130A9 |
127.01 | 90.20 | 0.52 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9) | 12390-131F5 |
130.24 | 90.25 | 0.42 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9) | 12512-133B1 |
137.14 | 67.67 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10) | 12269-130B1 |
123.13 | 73.60 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10) | 12391-131F6 |
106.12 | 70.93 | 0.19 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10) | 12513-133B2 |
124.05 | 56.83 | 0.32 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11) | 12270-130B2 |
113.88 | 80.44 | 0.48 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11) | 12392-131F7 |
105.85 | 60.87 | 0.33 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11) | 12514-133B3 |
125.25 | 62.44 | 0.25 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 12271-130B3 |
159.19 | 118.10 | 1.48 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12) | 12393-131F8 |
107.73 | 70.91 | 0.74 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12) | 12515-133B4 |
117.69 | 58.30 | 0.14 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13) | 12272-130B4 |
142.81 | 90.06 | 0.32 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13) | 12394-131F9 |
134.51 | 89.17 | 0.30 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13) | 12516-133B5 |
157.18 | 80.76 | 0.42 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14) | 12273-130B5 |
147.20 | 97.07 | 0.36 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14) | 12395-131G1 |
86.29 | 50.42 | 0.97 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14) | 12517-133B6 |
89.16 | 48.39 | 0.16 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15) | 12274-130B6 |
114.59 | 75.20 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15) | 12396-131G2 |
99.64 | 62.72 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15) | 12518-133B7 |
102.88 | 42.61 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16) | 12275-130B7 |
116.33 | 126.35 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16) | 12397-131G3 |
80.94 | 44.05 | 0.00 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16) | 12519-133B8 |
134.86 | 61.16 | 0.30 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1 | 13031-139E7 |
172.22 | 135.96 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2 | 13097-140D1 |
194.85 | 158.80 | 0.77 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3 | 13163-141B4 |
161.81 | 141.77 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1 | 13032-139E8 |
185.75 | 145.98 | 2.96 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2 | 13098-140D2 |
161.06 | 124.49 | 0.70 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3 | 13164-141B5 |
164.38 | 128.89 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1 | 13033-139E9 |
190.13 | 130.36 | 0.52 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 | 13099-140D3 |
189.12 | 152.25 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3 | 13165-141B6 |
139.33 | 114.68 | 0.68 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1 | 13034-139F1 |
251.86 | 197.47 | 2.91 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2 | 13100-140D4 |
227.34 | 173.32 | 3.15 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3 | 13166-141B7 |
161.77 | 136.84 | 1.49 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1 | 13035-139F2 |
236.73 | 140.71 | 1.54 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2 | 13101-140D5 |
228.65 | 161.61 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 13167-141B8 |
212.55 | 120.60 | 0.67 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1 | 13036-139F3 |
227.70 | 161.48 | 3.57 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 13102-140D6 |
232.65 | 183.03 | 1.07 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3 | 13168-141B9 |
272.46 | 229.76 | 1.32 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1 | 13037-139F4 |
233.15 | 168.73 | 3.07 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2 | 13103-140D7 |
220.98 | 176.95 | 0.82 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3 | 13169-141C1 |
275.71 | 199.71 | 0.62 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1 | 13038-139F5 |
275.78 | 195.90 | 1.68 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2 | 13104-140D8 |
217.40 | 157.64 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3 | 13170-141C2 |
256.63 | 191.60 | 1.74 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 13039-139F6 |
263.66 | 168.90 | 1.49 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2 | 13105-140D9 |
227.39 | 165.98 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3 | 13171-141C3 |
220.93 | 196.89 | 1.06 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1 | 13040-139F7 |
245.24 | 177.38 | 2.21 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2 | 13106-140E1 |
201.47 | 148.51 | 2.30 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3 | 13172-141C4 |
222.96 | 163.48 | 1.92 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1 | 13041-139F8 |
243.44 | 185.12 | 2.83 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2 | 13107-140E2 |
212.50 | 184.61 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3 | 13173-141C5 |
196.12 | 165.84 | 1.36 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1 | 13042-139F9 |
219.75 | 185.28 | 0.72 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2 | 13108-140E3 |
229.30 | 168.05 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3 | 13174-141C6 |
245.25 | 162.01 | 1.11 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1 | 13043-139G1 |
261.46 | 180.48 | 0.43 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2 | 13109-140E4 |
212.36 | 173.83 | 0.86 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3 | 13175-141C7 |
251.88 | 180.92 | 0.67 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 13044-139G2 |
225.03 | 149.62 | 0.60 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2 | 13110-140E5 |
196.95 | 145.75 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3 | 13176-141C8 |
209.32 | 164.98 | 0.34 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1 | 13045-139G3 |
221.68 | 198.06 | 2.15 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2 | 13111-140E6 |
163.63 | 124.57 | 0.67 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3 | 13177-141C9 |
219.65 | 177.43 | 2.22 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1 | 13046-139G4 |
186.07 | 153.51 | 0.00 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 13112-140E7 |
202.03 | 144.91 | 1.06 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3 | 13178-141D1 |
220.48 | 181.27 | 0.80 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1 | 13048-139G6 |
199.89 | 130.84 | 1.45 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 13114-140E9 |
206.96 | 159.44 | 0.77 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3 | 13180-141D3 |
196.82 | 178.07 | 1.97 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1 | 13049-139G7 |
223.00 | 152.43 | 2.82 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 13115-140F1 |
195.09 | 151.35 | 1.01 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3 | 13181-141D4 |
223.96 | 169.43 | 1.35 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1 | 13050-139G8 |
201.37 | 189.32 | 6.88 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 13116-140F2 |
185.71 | 159.43 | 0.89 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3 | 13182-141D5 |
225.23 | 158.76 | 2.35 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1 | 13051-139G9 |
205.84 | 151.08 | 3.30 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 13117-140F3 |
209.13 | 162.42 | 1.56 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3 | 13183-141D6 |
283.11 | 181.59 | 3.06 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1 | 13052-139H1 |
246.00 | 159.34 | 1.68 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 13118-140F4 |
194.76 | 142.21 | 1.77 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3 | 13184-141D7 |
243.77 | 181.29 | 1.54 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1 | 13053-139H2 |
231.91 | 172.67 | 2.03 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 13119-140F5 |
235.50 | 167.26 | 1.44 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3 | 13185-141D8 |
233.76 | 179.29 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1 | 13054-139H3 |
251.56 | 168.31 | 1.22 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 13120-140F6 |
161.17 | 118.28 | 0.00 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3 | 13186-141D9 |
248.89 | 180.50 | 2.66 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1 | 13055-139H4 |
236.52 | 181.78 | 2.58 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 13121-140F7 |
160.23 | 97.95 | 1.21 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3 | 13187-141E1 |
237.04 | 182.53 | 1.90 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1 | 13056-139H5 |
278.81 | 159.39 | 0.00 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 13122-140F8 |
165.51 | 114.36 | 0.57 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3 | 13188-141E2 |
228.83 | 186.67 | 0.51 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1 | 13057-139H6 |
236.96 | 161.98 | 2.83 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 13123-140F9 |
188.41 | 122.58 | 0.57 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3 | 13189-141E3 |
221.74 | 184.30 | 0.42 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1 | 13058-139H7 |
236.48 | 176.18 | 2.35 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 13124-140G1 |
156.16 | 98.54 | 0.84 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3 | 13190-141E4 |
247.65 | 161.23 | 1.39 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1 | 13059-139H8 |
222.79 | 156.56 | 0.67 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 13125-140G2 |
190.87 | 106.93 | 0.53 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3 | 13191-141E5 |
262.26 | 168.51 | 1.21 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1 | 13060-139H9 |
235.86 | 156.02 | 0.00 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 13126-140G3 |
209.83 | 108.47 | 0.00 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3 | 13192-141E6 |
227.38 | 178.37 | 2.28 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1 | 13061-139I1 |
217.80 | 173.32 | 0.77 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 13127-140G4 |
203.00 | 130.23 | 0.55 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3 | 13193-141E7 |
215.15 | 151.90 | 2.23 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1 | 13062-139I2 |
191.33 | 123.74 | 0.00 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 13128-140G5 |
191.64 | 133.28 | 1.33 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3 | 13194-141E8 |
255.67 | 178.76 | 0.00 |
Macrophage - monocyte derived, donor1 | 11232-116C8 |
124.90 | 103.93 | 0.46 |
Macrophage - monocyte derived, donor2 | 11313-117C8 |
110.65 | 75.97 | 0.18 |
Macrophage - monocyte derived, donor3 | 11389-118C3 |
176.83 | 90.58 | 0.26 |
Mallassez-derived cells, donor1 (MZH3) | 12142-128E9 |
110.98 | 92.40 | 0.00 |
Mallassez-derived cells, donor2 | 11929-125I3 |
139.28 | 125.97 | 0.16 |
Mallassez-derived cells, donor3 | 11930-125I4 |
180.96 | 150.25 | 0.14 |
Mammary Epithelial Cell, donor1 | 11273-116H4 |
211.04 | 109.11 | 0.20 |
Mammary Epithelial Cell, donor2 | 11350-117G9 |
209.05 | 99.61 | 0.58 |
Mammary Epithelial Cell, donor3 | 11422-118F9 |
181.83 | 75.83 | 0.25 |
Mast cell - stimulated, donor1 | 11487-119E2 |
679.29 | 456.93 | 2.03 |
Mast cell, donor1 | 11563-120D6 |
203.41 | 243.86 | 0.76 |
Mast cell, donor2 | 11565-120D8 |
297.47 | 210.99 | 2.97 |
Mast cell, donor3 | 11566-120D9 |
289.51 | 268.35 | 5.18 |
Mast cell, donor4 | 11567-120E1 |
233.84 | 180.48 | 1.95 |
Mast cell, expanded and stimulated, donor5 | 11940-126A5 |
270.47 | 234.87 | 1.44 |
Mast cell, expanded and stimulated, donor8 | 11942-126A7 |
232.31 | 179.77 | 2.33 |
Mast cell, expanded, donor5 | 11939-126A4 |
204.66 | 172.54 | 0.92 |
Mast cell, expanded, donor8 | 11941-126A6 |
179.25 | 180.09 | 1.17 |
Melanocyte - dark, donor1 | 11502-119F8 |
167.45 | 155.52 | 0.00 |
Melanocyte - dark, donor2 | 11582-120F7 |
173.73 | 117.67 | 0.00 |
Melanocyte - dark, donor3 | 11663-122F7 |
149.95 | 131.91 | 0.14 |
Melanocyte - light, donor1 | 11274-116H5 |
72.17 | 59.94 | 0.00 |
Melanocyte - light, donor2 | 11351-117H1 |
71.66 | 48.46 | 0.00 |
Melanocyte - light, donor3 | 11423-118G1 |
74.58 | 52.03 | 0.00 |
Melanocyte, donor1 (MC+1) | 12641-134G4 |
160.77 | 105.79 | 0.10 |
Melanocyte, donor2 (MC+2) | 12739-135I3 |
176.96 | 86.87 | 0.54 |
Melanocyte, donor3 (MC+3) | 12837-137B2 |
177.59 | 127.23 | 0.00 |
Meningeal Cells, donor1 | 11493-119E8 |
185.59 | 100.86 | 0.12 |
Meningeal Cells, donor2 | 11573-120E7 |
231.96 | 102.11 | 0.00 |
Meningeal Cells, donor3 | 11654-122E7 |
294.47 | 185.66 | 0.33 |
Mesenchymal Stem Cells - Vertebral, donor1 | 11219-116B4 |
255.79 | 123.47 | 0.57 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1 | 11548-120B9 |
94.39 | 68.73 | 0.91 |
Mesenchymal Stem Cells - adipose, donor1 | 11537-120A7 |
22.34 | 15.77 | 0.00 |
Mesenchymal Stem Cells - adipose, donor2 | 11617-122A6 |
94.19 | 17.01 | 0.00 |
Mesenchymal Stem Cells - adipose, donor3 | 11698-123A6 |
225.33 | 96.16 | 0.00 |
Mesenchymal Stem Cells - amniotic membrane, donor1 | 11547-120B8 |
112.87 | 81.32 | 0.42 |
Mesenchymal Stem Cells - amniotic membrane, donor2 | 11627-122B7 |
172.91 | 69.37 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor1 | 11536-120A6 |
121.96 | 47.69 | 0.22 |
Mesenchymal Stem Cells - bone marrow, donor2 | 11616-122A5 |
176.07 | 57.72 | 0.00 |
Mesenchymal Stem Cells - bone marrow, donor3 | 11697-123A5 |
135.86 | 36.01 | 0.20 |
Mesenchymal Stem Cells - bone marrow, donor4 | 11464-119B6 |
100.28 | 85.60 | 0.00 |
Mesenchymal Stem Cells - hepatic, donor1 | 11538-120A8 |
38.66 | 30.11 | 0.00 |
Mesenchymal Stem Cells - hepatic, donor2 | 11618-122A7 |
153.81 | 138.42 | 0.79 |
Mesenchymal Stem Cells - umbilical, donor1 | 11539-120A9 |
54.01 | 35.61 | 0.00 |
Mesenchymal Stem Cells - umbilical, donor2 | 11619-122A8 |
72.40 | 32.70 | 0.00 |
Mesenchymal Stem Cells - umbilical, donor3 | 11700-123A8 |
179.31 | 53.15 | 0.00 |
Mesenchymal stem cells - adipose, donor0 | 11217-116B2 |
248.47 | 108.11 | 0.00 |
Mesenchymal stem cells - hepatic, donor0 | 11218-116B3 |
141.35 | 124.78 | 1.25 |
Mesenchymal stem cells - umbilical, donor0 | 11214-116A8 |
246.01 | 125.54 | 0.73 |
Mesothelial Cells, donor1 | 11247-116E5 |
99.44 | 103.15 | 0.27 |
Mesothelial Cells, donor2 | 12156-128G5 |
79.07 | 56.55 | 0.00 |
Mesothelial Cells, donor3 | 11402-118D7 |
131.02 | 97.20 | 0.36 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1) | 12698-135D7 |
147.19 | 71.57 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 12796-136F6 |
179.29 | 109.84 | 0.49 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3) | 12894-137H5 |
147.82 | 72.44 | 0.88 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1) | 12699-135D8 |
58.77 | 20.74 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2) | 12797-136F7 |
123.36 | 78.11 | 0.62 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3) | 12895-137H6 |
117.20 | 65.34 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1) | 12700-135D9 |
62.53 | 11.58 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2) | 12798-136F8 |
139.40 | 87.59 | 0.75 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3) | 12896-137H7 |
157.33 | 61.44 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1) | 12701-135E1 |
97.33 | 38.93 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2) | 12799-136F9 |
135.95 | 92.26 | 0.61 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3) | 12897-137H8 |
120.77 | 49.89 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1) | 12702-135E2 |
51.31 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2) | 12800-136G1 |
82.30 | 69.91 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3) | 12898-137H9 |
123.86 | 71.43 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1) | 12703-135E3 |
69.74 | 11.84 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2) | 12801-136G2 |
116.51 | 84.04 | 0.21 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3) | 12899-137I1 |
96.69 | 30.39 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1) | 12704-135E4 |
0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2) | 12802-136G3 |
111.47 | 68.55 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3) | 12900-137I2 |
119.04 | 15.09 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1) | 12705-135E5 |
33.95 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2) | 12803-136G4 |
120.68 | 86.56 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3) | 12901-137I3 |
129.77 | 59.42 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1) | 12706-135E6 |
105.05 | 22.67 | 0.55 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2) | 12804-136G5 |
114.43 | 94.17 | 0.69 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3) | 12902-137I4 |
134.83 | 56.58 | 0.21 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1) | 12707-135E7 |
134.53 | 90.30 | 0.61 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2) | 12805-136G6 |
105.98 | 90.96 | 0.43 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3) | 12903-137I5 |
142.27 | 49.13 | 0.22 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1) | 12708-135E8 |
41.27 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2) | 12806-136G7 |
103.59 | 78.19 | 1.10 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3) | 12904-137I6 |
110.52 | 40.56 | 0.00 |
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1) | 12709-135E9 |
114.33 | 16.57 | 1.66 |
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2) | 12807-136G8 |
131.28 | 82.62 | 0.54 |
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3) | 12905-137I7 |
149.98 | 61.46 | 0.00 |
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1) | 12710-135F1 |
82.86 | 22.90 | 0.00 |
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2) | 12808-136G9 |
111.01 | 85.06 | 1.92 |
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3) | 12906-137I8 |
154.89 | 63.24 | 0.00 |
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 12711-135F2 |
139.86 | 27.42 | 4.11 |
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2) | 12809-136H1 |
125.14 | 94.11 | 1.50 |
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3) | 12907-137I9 |
26.95 | 26.95 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1) | 12712-135F3 |
103.96 | 50.96 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2) | 12810-136H2 |
175.17 | 95.90 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3) | 12908-138A1 |
129.13 | 23.18 | 0.00 |
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1) | 12713-135F4 |
160.74 | 33.94 | 0.64 |
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2) | 12811-136H3 |
174.29 | 129.17 | 0.25 |
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 12909-138A2 |
121.78 | 31.32 | 0.00 |
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1) | 12714-135F5 |
119.33 | 24.31 | 0.00 |
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2) | 12812-136H4 |
107.35 | 101.54 | 0.68 |
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3) | 12910-138A3 |
122.53 | 36.76 | 0.00 |
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1) | 12715-135F6 |
106.17 | 35.15 | 0.36 |
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 12813-136H5 |
117.55 | 77.43 | 0.28 |
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3) | 12911-138A4 |
146.72 | 38.65 | 0.42 |
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1) | 12716-135F7 |
100.82 | 23.31 | 0.00 |
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2) | 12814-136H6 |
90.50 | 57.92 | 0.30 |
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3) | 12912-138A5 |
135.23 | 67.20 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 12717-135F8 |
36.09 | 21.66 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2) | 12815-136H7 |
106.21 | 39.71 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3) | 12913-138A6 |
175.29 | 67.73 | 0.57 |
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1) | 12718-135F9 |
101.84 | 64.81 | 0.00 |
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2) | 12816-136H8 |
99.51 | 66.60 | 0.26 |
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3) | 12914-138A7 |
149.71 | 63.06 | 0.00 |
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1) | 12719-135G1 |
100.36 | 26.68 | 0.00 |
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2) | 12817-136H9 |
91.54 | 52.04 | 0.27 |
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 12915-138A8 |
159.84 | 81.42 | 0.00 |
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1) | 12720-135G2 |
98.45 | 53.39 | 0.14 |
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2) | 12818-136I1 |
88.55 | 68.80 | 0.32 |
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3) | 12916-138A9 |
140.42 | 63.46 | 0.00 |
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1) | 12721-135G3 |
102.38 | 44.75 | 0.00 |
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2) | 12819-136I2 |
105.12 | 80.69 | 0.57 |
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3) | 12917-138B1 |
131.75 | 81.61 | 0.49 |
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1) | 12722-135G4 |
110.78 | 35.19 | 0.00 |
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2) | 12820-136I3 |
125.55 | 75.27 | 0.29 |
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3) | 12918-138B2 |
155.12 | 71.22 | 0.00 |
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1) | 12723-135G5 |
123.23 | 98.91 | 0.41 |
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2) | 12821-136I4 |
118.52 | 67.60 | 0.30 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 13304-142I1 |
109.24 | 71.57 | 3.77 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h) | 13316-143A4 |
103.37 | 46.34 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h) | 13322-143B1 |
148.84 | 126.83 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h) | 13310-142I7 |
124.13 | 55.75 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h) | 13309-142I6 |
87.18 | 95.09 | 0.20 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h) | 13321-143A9 |
157.39 | 107.10 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h) | 13327-143B6 |
182.88 | 139.32 | 0.00 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h) | 13315-143A3 |
141.43 | 60.99 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h) | 13305-142I2 |
101.00 | 107.11 | 0.23 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 13317-143A5 |
107.56 | 75.88 | 0.74 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h) | 13323-143B2 |
131.91 | 98.20 | 0.73 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h) | 13311-142I8 |
140.00 | 66.89 | 1.56 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h) | 13306-142I3 |
93.53 | 105.28 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h) | 13318-143A6 |
92.73 | 57.96 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h) | 13324-143B3 |
98.97 | 91.90 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 13312-142I9 |
129.86 | 58.19 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h) | 13307-142I4 |
72.18 | 74.91 | 1.36 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h) | 13319-143A7 |
56.59 | 68.03 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h) | 13325-143B4 |
86.65 | 75.31 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h) | 13313-143A1 |
92.14 | 43.80 | 3.02 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h) | 13308-142I5 |
211.28 | 119.91 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h) | 13320-143A8 |
137.02 | 150.07 | 13.05 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h) | 13326-143B5 |
104.55 | 80.79 | 0.00 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h) | 13314-143A2 |
200.78 | 37.65 | 12.55 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1 | 11549-120C1 |
124.74 | 121.51 | 0.22 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2 | 11629-122B9 |
190.23 | 121.25 | 0.52 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1 | 13496-145C4 |
164.20 | 66.75 | 0.00 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2 | 13505-145D4 |
169.45 | 44.66 | 0.00 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3 | 13514-145E4 |
616.82 | 197.94 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor1 | 13469-144I4 |
451.63 | 135.65 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor2 | 13478-145A4 |
148.91 | 47.60 | 0.00 |
Myoblast differentiation to myotubes, day00, control donor3 | 13487-145B4 |
735.06 | 220.52 | 0.00 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 13497-145C5 |
128.07 | 59.43 | 0.00 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2 | 13506-145D5 |
268.70 | 78.56 | 0.00 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3 | 13515-145E5 |
155.38 | 71.88 | 0.00 |
Myoblast differentiation to myotubes, day01, control donor1 | 13470-144I5 |
220.12 | 99.02 | 0.42 |
Myoblast differentiation to myotubes, day01, control donor2 | 13479-145A5 |
846.24 | 322.91 | 0.00 |
Myoblast differentiation to myotubes, day01, control donor3 | 13488-145B5 |
155.36 | 74.95 | 0.00 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 13498-145C6 |
211.12 | 82.82 | 0.27 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2 | 13507-145D6 |
130.57 | 63.70 | 0.00 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3 | 13516-145E6 |
162.00 | 57.32 | 0.00 |
Myoblast differentiation to myotubes, day02, control donor1 | 13471-144I6 |
163.30 | 110.99 | 0.55 |
Myoblast differentiation to myotubes, day02, control donor2 | 13480-145A6 |
141.63 | 90.17 | 0.53 |
Myoblast differentiation to myotubes, day02, control donor3 | 13489-145B6 |
118.26 | 61.83 | 0.00 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1 | 13499-145C7 |
301.27 | 179.84 | 0.33 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 13508-145D7 |
120.18 | 45.37 | 0.00 |
Myoblast differentiation to myotubes, day03, control donor1 | 13472-144I7 |
172.68 | 103.89 | 0.18 |
Myoblast differentiation to myotubes, day03, control donor2 | 13481-145A7 |
123.77 | 67.51 | 0.70 |
Myoblast differentiation to myotubes, day03, control donor3 | 13490-145B7 |
144.35 | 57.92 | 0.00 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1 | 13500-145C8 |
136.25 | 71.34 | 0.00 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 13509-145D8 |
334.20 | 169.34 | 0.00 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 13518-145E8 |
763.59 | 260.43 | 2.53 |
Myoblast differentiation to myotubes, day04, control donor1 | 13473-144I8 |
156.17 | 80.20 | 0.67 |
Myoblast differentiation to myotubes, day04, control donor2 | 13482-145A8 |
147.34 | 54.19 | 0.00 |
Myoblast differentiation to myotubes, day04, control donor3 | 13491-145B8 |
221.92 | 78.56 | 0.47 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 13501-145C9 |
137.36 | 87.14 | 0.43 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 13510-145D9 |
622.92 | 315.97 | 0.00 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3 | 13519-145E9 |
168.28 | 70.64 | 0.00 |
Myoblast differentiation to myotubes, day06, control donor1 | 13474-144I9 |
128.05 | 59.51 | 0.45 |
Myoblast differentiation to myotubes, day06, control donor2 | 13483-145A9 |
119.83 | 55.16 | 0.40 |
Myoblast differentiation to myotubes, day06, control donor3 | 13492-145B9 |
117.01 | 72.43 | 0.00 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 13502-145D1 |
232.32 | 98.00 | 0.76 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2 | 13511-145E1 |
109.50 | 49.21 | 0.00 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3 | 13520-145F1 |
104.59 | 40.53 | 0.00 |
Myoblast differentiation to myotubes, day08, control donor1 | 13475-145A1 |
160.11 | 88.20 | 0.00 |
Myoblast differentiation to myotubes, day08, control donor2 | 13484-145B1 |
79.37 | 63.50 | 0.00 |
Myoblast differentiation to myotubes, day08, control donor3 | 13493-145C1 |
117.68 | 67.81 | 0.00 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 13503-145D2 |
152.78 | 83.34 | 0.00 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 13512-145E2 |
101.45 | 47.47 | 0.00 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3 | 13521-145F2 |
238.93 | 101.32 | 0.30 |
Myoblast differentiation to myotubes, day10, control donor1 | 13476-145A2 |
144.11 | 88.19 | 0.66 |
Myoblast differentiation to myotubes, day10, control donor2 | 13485-145B2 |
125.37 | 52.86 | 0.00 |
Myoblast differentiation to myotubes, day10, control donor3 | 13494-145C2 |
648.91 | 281.02 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 13504-145D3 |
138.40 | 92.67 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 13513-145E3 |
111.10 | 51.30 | 0.00 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 13522-145F3 |
124.39 | 57.81 | 0.91 |
Myoblast differentiation to myotubes, day12, control donor1 | 13477-145A3 |
99.68 | 83.86 | 0.00 |
Myoblast differentiation to myotubes, day12, control donor2 | 13486-145B3 |
340.09 | 139.44 | 3.40 |
Myoblast differentiation to myotubes, day12, control donor3 | 13495-145C3 |
556.37 | 328.76 | 5.06 |
Myoblast, donor1 | 11241-116D8 |
124.85 | 63.11 | 0.12 |
Myoblast, donor2 | 11322-117D8 |
200.04 | 125.05 | 0.96 |
Myoblast, donor3 | 11398-118D3 |
143.44 | 108.80 | 0.50 |
NK T cell leukemia cell line:KHYG-1 | 10777-110G3 |
286.32 | 233.64 | 0.00 |
Natural Killer Cells, donor1 | 11230-116C6 |
260.16 | 216.49 | 7.38 |
Natural Killer Cells, donor2 | 11311-117C6 |
317.84 | 150.78 | 15.08 |
Natural Killer Cells, donor3 | 11387-118C1 |
279.95 | 204.30 | 12.52 |
Neural stem cells, donor1 | 11275-116H6 |
387.26 | 350.24 | 0.73 |
Neural stem cells, donor2 | 11352-117H2 |
396.68 | 259.96 | 1.93 |
Neurons, donor1 | 11494-119E9 |
386.89 | 262.85 | 0.00 |
Neurons, donor2 | 11574-120E8 |
283.79 | 220.60 | 1.10 |
Neurons, donor3 | 11655-122E8 |
413.55 | 268.03 | 4.11 |
Neutrophils, donor1 | 11233-116C9 |
726.63 | 356.35 | 5.57 |
Neutrophils, donor2 | 11314-117C9 |
710.22 | 246.40 | 11.60 |
Neutrophils, donor3 | 11390-118C4 |
799.59 | 522.27 | 1.83 |
Nucleus Pulposus Cell, donor1 | 11252-116F1 |
192.59 | 180.24 | 0.12 |
Nucleus Pulposus Cell, donor2 | 11409-118E5 |
176.15 | 77.17 | 0.00 |
Nucleus Pulposus Cell, donor3 | 11462-119B4 |
161.65 | 88.04 | 0.00 |
Olfactory epithelial cells, donor1 | 11933-125I7 |
154.58 | 96.91 | 0.28 |
Olfactory epithelial cells, donor2 | 11934-125I8 |
213.50 | 110.73 | 1.16 |
Olfactory epithelial cells, donor3 | 11935-125I9 |
168.55 | 96.59 | 0.45 |
Olfactory epithelial cells, donor4 | 11936-126A1 |
158.56 | 101.29 | 0.39 |
Oligodendrocyte - precursors, donor1 | 11496-119F2 |
168.51 | 149.25 | 0.00 |
Osteoblast - differentiated, donor1 | 11276-116H7 |
77.21 | 70.61 | 0.00 |
Osteoblast - differentiated, donor2 | 11353-117H3 |
56.01 | 34.29 | 0.00 |
Osteoblast - differentiated, donor3 | 11425-118G3 |
75.73 | 53.38 | 0.00 |
Osteoblast, donor1 | 11277-116H8 |
141.50 | 112.77 | 0.59 |
Osteoblast, donor2 | 11354-117H4 |
257.75 | 171.37 | 0.70 |
Osteoblast, donor3 | 11426-118G4 |
229.98 | 116.77 | 0.00 |
Pancreatic stromal cells, donor1 | 11249-116E7 |
205.62 | 125.01 | 0.59 |
Pericytes, donor1 | 11491-119E6 |
29.04 | 15.24 | 0.00 |
Pericytes, donor2 | 11571-120E5 |
61.12 | 23.99 | 0.00 |
Pericytes, donor3 | 11652-122E5 |
101.72 | 48.42 | 0.20 |
Perineurial Cells, donor1 | 11499-119F5 |
148.62 | 115.06 | 0.90 |
Perineurial Cells, donor2 | 11579-120F4 |
172.15 | 142.71 | 0.18 |
Peripheral Blood Mononuclear Cells, donor1 | 11231-116C7 |
326.39 | 273.16 | 13.71 |
Peripheral Blood Mononuclear Cells, donor2 | 11312-117C7 |
326.89 | 217.93 | 7.59 |
Peripheral Blood Mononuclear Cells, donor3 | 11388-118C2 |
327.68 | 173.93 | 2.98 |
Placental Epithelial Cells, donor1 | 11278-116H9 |
68.64 | 77.49 | 0.24 |
Placental Epithelial Cells, donor2 | 11355-117H5 |
74.30 | 92.04 | 0.00 |
Placental Epithelial Cells, donor3 | 11427-118G5 |
111.71 | 66.95 | 0.00 |
Preadipocyte - breast donor2 (cytoplasmic fraction) | 14319-155D8 |
73.73 | 43.99 | 0.00 |
Preadipocyte - breast, donor1 | 11467-119B9 |
87.79 | 63.97 | 0.56 |
Preadipocyte - breast, donor2 (nuclear fraction) | 14320-155D9 |
185.87 | 232.21 | 1.17 |
Preadipocyte - breast, donor2 | 11328-117E5 |
115.28 | 92.09 | 0.23 |
Preadipocyte - omental, donor1 | 11468-119C1 |
96.86 | 92.81 | 0.43 |
Preadipocyte - omental, donor2 | 11329-117E6 |
95.15 | 82.49 | 0.44 |
Preadipocyte - omental, donor3 | 11403-118D8 |
137.23 | 94.69 | 0.00 |
Preadipocyte - perirenal, donor1 | 11469-119C2 |
73.82 | 51.18 | 0.00 |
Preadipocyte - subcutaneous, donor1 | 11279-116I1 |
96.13 | 70.94 | 0.31 |
Preadipocyte - subcutaneous, donor2 | 11356-117H6 |
347.78 | 168.22 | 0.53 |
Preadipocyte - subcutaneous, donor3 | 11428-118G6 |
221.88 | 112.05 | 0.00 |
Preadipocyte - visceral, donor1 | 11280-116I2 |
265.47 | 171.58 | 0.75 |
Preadipocyte - visceral, donor2 | 11357-117H7 |
242.05 | 164.28 | 1.38 |
Preadipocyte - visceral, donor3 | 11429-118G7 |
236.15 | 107.10 | 0.21 |
Prostate Epithelial Cells (polarized), donor1 | 11253-116F2 |
159.15 | 133.50 | 0.15 |
Prostate Epithelial Cells, donor2 | 11331-117E8 |
126.34 | 73.80 | 0.41 |
Prostate Epithelial Cells, donor3 | 11404-118D9 |
89.90 | 81.08 | 0.00 |
Prostate Stromal Cells, donor1 | 11254-116F3 |
214.02 | 118.46 | 0.34 |
Prostate Stromal Cells, donor2 | 11332-117E9 |
226.45 | 137.52 | 0.18 |
Prostate Stromal Cells, donor3 | 11405-118E1 |
130.97 | 102.09 | 0.00 |
Renal Cortical Epithelial Cells, donor1 | 11516-119H4 |
90.15 | 32.85 | 0.00 |
Renal Cortical Epithelial Cells, donor2 | 11596-120H3 |
154.22 | 113.05 | 0.35 |
Renal Epithelial Cells, donor1 | 11517-119H5 |
62.39 | 19.27 | 0.00 |
Renal Epithelial Cells, donor2 | 11597-120H4 |
109.54 | 32.72 | 0.00 |
Renal Epithelial Cells, donor3 | 11678-122H4 |
176.79 | 122.70 | 0.21 |
Renal Glomerular Endothelial Cells, donor1 | 11514-119H2 |
91.23 | 29.28 | 0.00 |
Renal Glomerular Endothelial Cells, donor2 | 11594-120H1 |
154.57 | 74.12 | 0.00 |
Renal Glomerular Endothelial Cells, donor3 | 11675-122H1 |
271.96 | 146.08 | 0.00 |
Renal Glomerular Endothelial Cells, donor4 | 11783-124B1 |
47.91 | 30.61 | 0.00 |
Renal Mesangial Cells, donor1 | 11518-119H6 |
92.44 | 50.84 | 0.22 |
Renal Mesangial Cells, donor2 | 11598-120H5 |
142.33 | 50.79 | 0.00 |
Renal Mesangial Cells, donor3 | 11679-122H5 |
57.70 | 22.47 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor1 | 11515-119H3 |
164.01 | 100.39 | 0.00 |
Renal Proximal Tubular Epithelial Cell, donor2 | 11595-120H2 |
106.27 | 45.54 | 0.42 |
Renal Proximal Tubular Epithelial Cell, donor3 | 11676-122H2 |
159.87 | 53.03 | 0.39 |
Retinal Pigment Epithelial Cells, donor0 | 11215-116A9 |
220.65 | 154.27 | 0.00 |
Retinal Pigment Epithelial Cells, donor1 | 11528-119I7 |
110.29 | 65.09 | 0.28 |
Retinal Pigment Epithelial Cells, donor2 | 11608-120I6 |
109.09 | 34.99 | 0.00 |
Retinal Pigment Epithelial Cells, donor3 | 11689-122I6 |
176.64 | 150.04 | 0.75 |
SABiosciences XpressRef Human Universal Total RNA, pool1 | 10002-101A5 |
206.20 | 205.40 | 2.27 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17) | 12697-135D6 |
417.22 | 167.96 | 1.79 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17) | 12795-136F5 |
314.81 | 340.13 | 1.65 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17) | 12893-137H4 |
453.60 | 256.38 | 0.58 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0) | 12662-134I7 |
292.04 | 151.09 | 0.78 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0) | 12760-136B6 |
350.45 | 155.91 | 1.99 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0) | 12858-137D5 |
308.52 | 215.72 | 2.12 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1) | 12663-134I8 |
404.63 | 277.61 | 1.98 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1) | 12761-136B7 |
343.11 | 172.02 | 0.58 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1) | 12859-137D6 |
422.74 | 229.28 | 2.54 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2) | 12664-134I9 |
309.82 | 150.87 | 0.41 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2) | 12762-136B8 |
357.31 | 181.98 | 1.36 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 12860-137D7 |
266.28 | 165.03 | 1.43 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3) | 12665-135A1 |
291.50 | 162.39 | 0.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 12763-136B9 |
337.18 | 186.83 | 1.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3) | 12861-137D8 |
366.42 | 188.08 | 1.99 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4) | 12666-135A2 |
284.47 | 142.04 | 0.57 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4) | 12764-136C1 |
368.09 | 167.32 | 1.68 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4) | 12862-137D9 |
386.34 | 240.71 | 2.25 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5) | 12667-135A3 |
346.23 | 153.14 | 0.53 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5) | 12765-136C2 |
352.86 | 172.68 | 1.07 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5) | 12863-137E1 |
368.93 | 194.97 | 1.53 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6) | 12668-135A4 |
301.37 | 155.38 | 0.43 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6) | 12766-136C3 |
324.59 | 172.11 | 1.12 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6) | 12864-137E2 |
366.75 | 181.15 | 1.20 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7) | 12669-135A5 |
326.74 | 143.13 | 0.36 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7) | 12767-136C4 |
333.93 | 160.53 | 1.10 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7) | 12865-137E3 |
376.50 | 179.99 | 1.21 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8) | 12670-135A6 |
274.08 | 177.14 | 0.47 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8) | 12768-136C5 |
375.00 | 167.86 | 0.99 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8) | 12866-137E4 |
394.50 | 184.04 | 2.34 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9) | 12671-135A7 |
297.14 | 150.33 | 0.21 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9) | 12769-136C6 |
421.18 | 223.64 | 0.22 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9) | 12867-137E5 |
384.14 | 162.09 | 1.25 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10) | 12672-135A8 |
328.39 | 155.71 | 0.40 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10) | 12770-136C7 |
408.37 | 167.57 | 1.36 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10) | 12868-137E6 |
382.31 | 172.55 | 1.74 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11) | 12673-135A9 |
283.01 | 169.53 | 0.34 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11) | 12771-136C8 |
380.64 | 141.42 | 1.23 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11) | 12869-137E7 |
401.72 | 186.00 | 0.99 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12) | 12674-135B1 |
315.98 | 156.28 | 0.34 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 12772-136C9 |
387.20 | 184.21 | 1.63 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12) | 12870-137E8 |
366.77 | 191.92 | 0.53 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 12675-135B2 |
305.15 | 174.63 | 0.41 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13) | 12773-136D1 |
356.68 | 184.05 | 1.90 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13) | 12871-137E9 |
401.47 | 227.94 | 1.01 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14) | 12676-135B3 |
262.18 | 169.70 | 0.75 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14) | 12774-136D2 |
372.07 | 223.24 | 1.75 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14) | 12872-137F1 |
345.43 | 212.15 | 0.60 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15) | 12677-135B4 |
254.32 | 165.83 | 0.37 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 12775-136D3 |
360.82 | 277.28 | 2.47 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15) | 12873-137F2 |
333.42 | 246.41 | 4.26 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16) | 12678-135B5 |
263.12 | 172.10 | 0.60 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16) | 12776-136D4 |
348.56 | 220.08 | 1.58 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16) | 12874-137F3 |
348.37 | 216.57 | 2.10 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17) | 12679-135B6 |
220.80 | 177.35 | 0.59 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17) | 12777-136D5 |
315.04 | 221.34 | 1.07 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17) | 12875-137F4 |
328.73 | 221.16 | 1.20 |
Schwann Cells, donor1 | 11498-119F4 |
98.55 | 26.71 | 0.00 |
Schwann Cells, donor2 | 11578-120F3 |
207.55 | 102.07 | 0.00 |
Schwann Cells, donor3 | 11659-122F3 |
183.37 | 74.93 | 0.88 |
Sebocyte, donor1 | 11220-116B5 |
204.87 | 113.94 | 0.00 |
Sebocyte, donor2 | 11301-117B5 |
165.90 | 88.23 | 0.00 |
Sebocyte, donor3 | 11378-118B1 |
128.20 | 75.64 | 0.00 |
Sertoli Cells, donor1 | 11255-116F4 |
160.69 | 135.84 | 0.00 |
Sertoli Cells, donor2 | 11333-117F1 |
149.69 | 81.91 | 0.00 |
Skeletal Muscle Cells, donor1 | 11281-116I3 |
170.41 | 146.48 | 0.53 |
Skeletal Muscle Cells, donor2 | 11358-117H8 |
49.15 | 33.97 | 0.00 |
Skeletal Muscle Cells, donor3 | 11430-118G8 |
211.52 | 100.32 | 0.00 |
Skeletal Muscle Cells, donor4 | 11451-119A2 |
300.21 | 114.99 | 0.47 |
Skeletal Muscle Cells, donor5 | 11455-119A6 |
282.13 | 99.00 | 0.45 |
Skeletal Muscle Cells, donor6 | 11459-119B1 |
348.90 | 116.35 | 0.31 |
Skeletal Muscle Satellite Cells, donor1 | 11240-116D7 |
233.99 | 148.69 | 1.13 |
Skeletal Muscle Satellite Cells, donor2 | 11321-117D7 |
251.70 | 84.19 | 0.29 |
Skeletal Muscle Satellite Cells, donor3 | 11397-118D2 |
345.85 | 160.62 | 0.10 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1 | 11282-116I4 |
174.49 | 150.90 | 0.67 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2 | 11359-117H9 |
170.08 | 73.82 | 0.72 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3 | 11431-118G9 |
145.72 | 76.92 | 0.14 |
Skin - palm, donor1 | 10286-104F7 |
448.58 | 75.21 | 0.00 |
Small Airway Epithelial Cells donor2 (cytoplasmic fraction) | 14334-155F5 |
125.70 | 35.17 | 0.00 |
Small Airway Epithelial Cells donor2 (nuclear fraction) | 14335-155F6 |
350.06 | 100.60 | 0.00 |
Small Airway Epithelial Cells donor3 (cytoplasmic fraction) | 14316-155D5 |
126.32 | 65.95 | 0.13 |
Small Airway Epithelial Cells, donor1 | 11256-116F5 |
133.03 | 100.36 | 0.42 |
Small Airway Epithelial Cells, donor2 | 11334-117F2 |
175.40 | 72.16 | 0.42 |
Small Airway Epithelial Cells, donor3 (nuclear fraction) | 14317-155D6 |
207.43 | 184.38 | 3.81 |
Small Airway Epithelial Cells, donor3 | 11406-118E2 |
127.27 | 71.95 | 0.07 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction) | 14313-155D2 |
86.09 | 39.81 | 0.00 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction) | 14314-155D3 |
136.51 | 110.05 | 0.44 |
Smooth Muscle Cells - Aortic, donor0 | 11210-116A4 |
89.94 | 56.43 | 0.00 |
Smooth Muscle Cells - Aortic, donor1 | 11283-116I5 |
83.09 | 138.12 | 0.00 |
Smooth Muscle Cells - Aortic, donor2 | 11360-117I1 |
91.36 | 68.52 | 0.00 |
Smooth Muscle Cells - Aortic, donor3 | 11432-118H1 |
90.39 | 64.90 | 0.00 |
Smooth Muscle Cells - Bladder, donor1 | 11519-119H7 |
196.15 | 161.12 | 2.00 |
Smooth Muscle Cells - Brachiocephalic, donor1 | 11284-116I6 |
90.63 | 74.79 | 0.00 |
Smooth Muscle Cells - Brachiocephalic, donor2 | 11361-117I2 |
160.92 | 92.65 | 0.00 |
Smooth Muscle Cells - Brachiocephalic, donor3 | 11433-118H2 |
180.14 | 93.46 | 0.64 |
Smooth Muscle Cells - Brain Vascular, donor1 | 11234-116D1 |
127.96 | 80.10 | 0.65 |
Smooth Muscle Cells - Brain Vascular, donor2 | 11315-117D1 |
117.83 | 91.55 | 0.30 |
Smooth Muscle Cells - Brain Vascular, donor3 | 11391-118C5 |
118.16 | 71.61 | 0.00 |
Smooth Muscle Cells - Bronchial, donor1 | 11512-119G9 |
47.34 | 16.76 | 0.00 |
Smooth Muscle Cells - Bronchial, donor2 | 11592-120G8 |
185.10 | 82.20 | 0.00 |
Smooth Muscle Cells - Carotid, donor1 | 11285-116I7 |
101.03 | 92.19 | 0.00 |
Smooth Muscle Cells - Carotid, donor2 | 11362-117I3 |
55.09 | 397.85 | 0.00 |
Smooth Muscle Cells - Carotid, donor3 | 11434-118H3 |
113.96 | 81.54 | 0.00 |
Smooth Muscle Cells - Colonic, donor1 | 11239-116D6 |
147.47 | 94.83 | 0.59 |
Smooth Muscle Cells - Colonic, donor2 | 11320-117D6 |
179.72 | 102.02 | 0.43 |
Smooth Muscle Cells - Colonic, donor3 | 11396-118D1 |
205.09 | 122.59 | 0.10 |
Smooth Muscle Cells - Coronary Artery, donor1 | 11286-116I8 |
94.35 | 67.59 | 0.00 |
Smooth Muscle Cells - Coronary Artery, donor2 | 11363-117I4 |
109.94 | 44.19 | 0.00 |
Smooth Muscle Cells - Coronary Artery, donor3 | 11435-118H4 |
141.06 | 83.98 | 0.00 |
Smooth Muscle Cells - Esophageal, donor1 | 11508-119G5 |
68.62 | 31.41 | 0.00 |
Smooth Muscle Cells - Esophageal, donor2 | 11588-120G4 |
175.20 | 144.73 | 0.79 |
Smooth Muscle Cells - Internal Thoracic Artery, donor1 | 11287-116I9 |
120.47 | 84.64 | 0.10 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 11364-117I5 |
118.78 | 89.66 | 0.00 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 11436-118H5 |
105.67 | 66.42 | 0.60 |
Smooth Muscle Cells - Intestinal, donor1 | 11509-119G6 |
322.15 | 216.97 | 0.00 |
Smooth Muscle Cells - Prostate, donor1 | 11257-116F6 |
161.26 | 107.19 | 0.27 |
Smooth Muscle Cells - Prostate, donor2 | 11335-117F3 |
168.80 | 98.05 | 0.13 |
Smooth Muscle Cells - Prostate, donor3 | 11465-119B7 |
81.68 | 68.74 | 0.25 |
Smooth Muscle Cells - Pulmonary Artery, donor1 | 11288-117A1 |
162.68 | 119.71 | 0.00 |
Smooth Muscle Cells - Pulmonary Artery, donor2 | 11365-117I6 |
105.02 | 78.02 | 0.75 |
Smooth Muscle Cells - Pulmonary Artery, donor3 | 11437-118H6 |
144.73 | 438.06 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor1 | 11289-117A2 |
98.59 | 80.46 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor2 | 11366-117I7 |
110.06 | 84.82 | 0.00 |
Smooth Muscle Cells - Subclavian Artery, donor3 | 11438-118H7 |
96.53 | 58.29 | 0.00 |
Smooth Muscle Cells - Tracheal, donor1 | 11513-119H1 |
38.94 | 25.07 | 0.29 |
Smooth Muscle Cells - Tracheal, donor2 | 11593-120G9 |
275.66 | 164.70 | 0.00 |
Smooth Muscle Cells - Tracheal, donor3 | 11674-122G9 |
165.84 | 112.59 | 0.00 |
Smooth Muscle Cells - Umbilical Artery, donor1 | 11290-117A3 |
89.09 | 76.42 | 0.14 |
Smooth Muscle Cells - Umbilical Artery, donor2 | 11367-117I8 |
165.72 | 112.18 | 0.25 |
Smooth Muscle Cells - Umbilical Artery, donor3 | 11439-118H8 |
171.11 | 78.97 | 0.00 |
Smooth Muscle Cells - Umbilical Vein, donor1 | 11541-120B2 |
202.35 | 136.67 | 0.14 |
Smooth Muscle Cells - Umbilical Vein, donor2 | 11621-122B1 |
122.67 | 88.90 | 0.08 |
Smooth Muscle Cells - Umbilical Vein, donor3 | 11702-123B1 |
33.81 | 8.57 | 0.00 |
Smooth Muscle Cells - Umbilical artery, donor0 | 11212-116A6 |
95.42 | 72.91 | 0.00 |
Smooth Muscle Cells - Uterine, donor1 | 11258-116F7 |
118.21 | 96.11 | 0.22 |
Smooth Muscle Cells - Uterine, donor3 | 11466-119B8 |
131.95 | 105.91 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor1 | 11960-126C7 |
133.72 | 62.58 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor2 | 11961-126C8 |
115.30 | 62.94 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor3 | 11962-126C9 |
120.51 | 111.96 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor4 | 11963-126D1 |
153.80 | 62.88 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor5 | 11964-126D2 |
126.62 | 44.29 | 0.00 |
Smooth muscle cells - airway, asthmatic, donor6 | 11965-126D3 |
304.85 | 127.22 | 0.79 |
Smooth muscle cells - airway, control, donor1 | 11966-126D4 |
137.13 | 83.04 | 0.00 |
Smooth muscle cells - airway, control, donor2 | 11967-126D5 |
129.38 | 53.91 | 0.80 |
Smooth muscle cells - airway, control, donor3 | 11968-126D6 |
107.85 | 69.81 | 0.42 |
Smooth muscle cells - airway, control, donor4 | 11969-126D7 |
131.09 | 55.92 | 0.00 |
Synoviocyte, donor1 | 11291-117A4 |
130.62 | 115.13 | 0.50 |
Synoviocyte, donor2 | 11368-117I9 |
113.15 | 100.91 | 0.34 |
Synoviocyte, donor3 | 11440-118H9 |
103.89 | 86.46 | 0.22 |
Trabecular Meshwork Cells, donor1 | 11532-120A2 |
192.96 | 48.60 | 0.36 |
Trabecular Meshwork Cells, donor2 | 11612-122A1 |
83.25 | 29.73 | 0.00 |
Trabecular Meshwork Cells, donor3 | 11693-123A1 |
102.34 | 39.36 | 0.00 |
Tracheal Epithelial Cells, donor1 | 11292-117A5 |
132.69 | 77.35 | 0.00 |
Tracheal Epithelial Cells, donor2 | 11369-118A1 |
104.37 | 53.73 | 0.00 |
Tracheal Epithelial Cells, donor3 | 11441-118I1 |
100.79 | 41.80 | 0.00 |
Universal RNA - Human Normal Tissues Biochain, pool1 | 10007-101B4 |
190.32 | 207.66 | 1.48 |
Urethra, donor2 | 10319-105A4 |
350.69 | 115.10 | 1.80 |
Urothelial Cells, donor1 | 11520-119H8 |
58.18 | 30.55 | 0.00 |
Urothelial Cells, donor2 | 11600-120H7 |
80.91 | 30.44 | 0.00 |
Urothelial Cells, donor3 | 11681-122H7 |
68.30 | 23.15 | 0.00 |
Urothelial cells, donor0 | 11216-116B1 |
151.35 | 100.53 | 0.45 |
Whole blood (ribopure), donor090309, donation1 | 12179-129A1 |
411.08 | 306.98 | 1.78 |
Whole blood (ribopure), donor090309, donation2 | 12180-129A2 |
396.00 | 333.10 | 2.86 |
Whole blood (ribopure), donor090309, donation3 | 12181-129A3 |
395.65 | 216.31 | 1.37 |
Whole blood (ribopure), donor090325, donation1 | 12176-128I7 |
321.96 | 225.20 | 2.07 |
Whole blood (ribopure), donor090325, donation2 | 12177-128I8 |
327.12 | 246.36 | 5.23 |
Whole blood (ribopure), donor090612, donation1 | 12182-129A4 |
333.20 | 265.52 | 6.25 |
Whole blood (ribopure), donor090612, donation2 | 12183-129A5 |
325.82 | 290.94 | 1.84 |
Whole blood (ribopure), donor090612, donation3 | 12184-129A6 |
390.72 | 198.10 | 0.91 |
Wilms' tumor cell line:G-401 | 10809-111A8 |
408.08 | 191.83 | 1.11 |
Wilms' tumor cell line:HFWT | 10597-108E3 |
201.53 | 112.65 | 0.88 |
acantholytic squamous carcinoma cell line:HCC1806 | 10717-109I6 |
324.01 | 160.89 | 1.12 |
achilles tendon, donor2 | 10292-104G4 |
252.12 | 150.86 | 0.00 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1 | 10455-106G5 |
345.98 | 207.53 | 0.51 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6 | 10534-107G3 |
469.46 | 355.23 | 0.70 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL | 10429-106D6 |
478.27 | 228.39 | 1.66 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat | 10464-106H5 |
347.76 | 280.28 | 0.00 |
acute myeloid leukemia (FAB M0) cell line:KG-1 | 10827-111C8 |
385.37 | 166.12 | 1.12 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3 | 10789-110H6 |
248.28 | 169.18 | 0.85 |
acute myeloid leukemia (FAB M1) cell line:HYT-1 | 10828-111C9 |
320.12 | 159.52 | 0.54 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1 | 10788-110H5 |
390.85 | 190.80 | 3.08 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6 | 10792-110H9 |
349.96 | 205.00 | 1.23 |
acute myeloid leukemia (FAB M2) cell line:NKM-1 | 10765-110E9 |
438.78 | 317.24 | 3.49 |
acute myeloid leukemia (FAB M3) cell line:HL60 | 10829-111D1 |
400.38 | 166.15 | 0.74 |
acute myeloid leukemia (FAB M4) cell line:FKH-1 | 10830-111D2 |
292.54 | 237.93 | 7.80 |
acute myeloid leukemia (FAB M4) cell line:HNT-34 | 10831-111D3 |
372.74 | 244.23 | 0.00 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1 | 10832-111D4 |
419.16 | 137.22 | 0.78 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3 | 10833-111D5 |
372.90 | 125.37 | 1.17 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1 | 10764-110E8 |
310.46 | 81.33 | 0.46 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ | 10770-110F5 |
368.89 | 125.02 | 0.00 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 14298-155B5 |
287.61 | 58.32 | 0.31 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh) | 10399-106A3 |
352.46 | 259.01 | 1.28 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived) | 10400-106A4 |
309.36 | 242.94 | 0.61 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed) | 10405-106A9 |
324.71 | 256.11 | 1.68 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4 | 10834-111D6 |
420.53 | 158.59 | 0.22 |
acute myeloid leukemia (FAB M6) cell line:EEB | 10835-111D7 |
572.70 | 185.12 | 0.67 |
acute myeloid leukemia (FAB M6) cell line:F-36E | 10836-111D8 |
509.15 | 143.08 | 0.00 |
acute myeloid leukemia (FAB M6) cell line:F-36P | 10837-111D9 |
327.69 | 169.87 | 0.75 |
acute myeloid leukemia (FAB M7) cell line:M-MOK | 10699-109G6 |
539.06 | 220.25 | 0.87 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1 | 10802-111A1 |
476.11 | 161.20 | 0.00 |
adenocarcinoma cell line:IM95m | 10796-110I4 |
226.55 | 225.84 | 0.00 |
adipose tissue, adult, pool1 | 10010-101C1 |
165.67 | 162.88 | 0.31 |
adipose, donor1 | 10184-103D4 |
1246.12 | 676.13 | 6.45 |
adipose, donor2 | 10185-103D5 |
270.08 | 72.18 | 6.49 |
adipose, donor3 | 10186-103D6 |
348.26 | 221.10 | 2.18 |
adipose, donor4 | 10187-103D7 |
411.71 | 553.85 | 3.47 |
adrenal cortex adenocarcinoma cell line:SW-13 | 10810-111A9 |
346.26 | 175.65 | 0.16 |
adrenal gland, adult, pool1 | 10081-102A9 |
163.70 | 94.58 | 0.00 |
adult T-cell leukemia cell line:ATN-1 | 10421-106C7 |
262.94 | 123.27 | 0.93 |
alveolar cell carcinoma cell line:SW 1573 | 10708-109H6 |
430.90 | 316.93 | 1.07 |
amniotic membrane cells, donor1 | 12235-129G3 |
142.12 | 145.60 | 1.62 |
amniotic membrane cells, donor2 | 12236-129G4 |
136.26 | 190.01 | 1.35 |
amniotic membrane cells, donor3 | 12237-129G5 |
163.80 | 116.07 | 0.59 |
amygdala - adult, donor10196 | 10167-103B5 |
310.68 | 128.07 | 0.00 |
amygdala, adult, donor10252 | 10151-102I7 |
242.31 | 174.99 | 0.81 |
amygdala, newborn, donor10223 | 10360-105E9 |
227.23 | 57.45 | 0.97 |
anaplastic carcinoma cell line:8305C | 10428-106D5 |
185.26 | 135.99 | 0.89 |
anaplastic large cell lymphoma cell line:Ki-JK | 10795-110I3 |
388.96 | 235.85 | 1.32 |
anaplastic squamous cell carcinoma cell line:RPMI 2650 | 10805-111A4 |
504.73 | 209.11 | 2.34 |
aorta, adult, pool1 | 10052-101G7 |
250.85 | 142.98 | 0.39 |
appendix, adult | 10189-103D9 |
294.58 | 168.83 | 0.78 |
argyrophil small cell carcinoma cell line:TC-YIK | 10589-108D4 |
225.62 | 252.79 | 1.03 |
artery, adult | 10190-103E1 |
154.89 | 129.08 | 0.00 |
astrocytoma cell line:TM-31 | 10425-106D2 |
254.82 | 263.22 | 0.58 |
b cell line:RPMI1788 | 10427-106D4 |
322.68 | 159.71 | 0.74 |
basal cell carcinoma cell line:TE 354.T | 10702-109G9 |
119.86 | 107.93 | 0.00 |
bile duct carcinoma cell line:HuCCT1 | 10432-106D9 |
206.70 | 153.51 | 0.50 |
bile duct carcinoma cell line:TFK-1 | 10496-107C1 |
154.49 | 171.90 | 1.34 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11 | 10718-109I7 |
271.23 | 148.20 | 1.68 |
bladder, adult, pool1 | 10011-101C2 |
201.20 | 139.60 | 0.22 |
blood, adult, pool1 | 10053-101G8 |
349.91 | 170.53 | 6.64 |
bone marrow stromal cell line:StromaNKtert | 10686-109F2 |
155.00 | 104.47 | 0.00 |
bone marrow, adult | 10192-103E3 |
236.19 | 172.76 | 2.02 |
brain, adult, donor1 | 10084-102B3 |
214.24 | 104.56 | 0.00 |
brain, adult, pool1 | 10012-101C3 |
220.27 | 131.18 | 0.33 |
brain, fetal, pool1 | 10085-102B4 |
347.28 | 149.60 | 0.00 |
breast carcinoma cell line:MCF7 | 10482-107A5 |
424.19 | 240.17 | 1.65 |
breast carcinoma cell line:MDA-MB-453 | 10419-106C5 |
200.22 | 151.53 | 0.62 |
breast, adult, donor1 | 10080-102A8 |
208.35 | 121.85 | 0.00 |
bronchial squamous cell carcinoma cell line:KNS-62 | 10760-110E4 |
289.90 | 249.63 | 0.76 |
bronchioalveolar carcinoma cell line:NCI-H358 | 10709-109H7 |
406.62 | 241.81 | 1.24 |
bronchioalveolar carcinoma cell line:NCI-H650 | 10715-109I4 |
233.44 | 220.78 | 1.38 |
bronchogenic carcinoma cell line:ChaGo-K-1 | 10710-109H8 |
328.03 | 151.55 | 0.73 |
carcinoid cell line:NCI-H1770 | 10703-109H1 |
325.83 | 149.04 | 5.17 |
carcinoid cell line:NCI-H727 | 10735-110B6 |
231.78 | 128.52 | 0.33 |
carcinoid cell line:SK-PN-DW | 10719-109I8 |
354.29 | 165.74 | 1.90 |
carcinosarcoma cell line:JHUCS-1 | 10642-109A3 |
484.98 | 254.73 | 1.33 |
caudate nucleus - adult, donor10196 | 10177-103C6 |
324.67 | 192.27 | 0.00 |
caudate nucleus, adult, donor10252 | 10164-103B2 |
218.86 | 156.78 | 0.17 |
caudate nucleus, adult, donor10258 | 10379-105H1 |
262.86 | 109.27 | 0.00 |
caudate nucleus, newborn, donor10223 | 10354-105E3 |
264.79 | 108.41 | 0.37 |
cerebellum - adult, donor10196 | 10173-103C2 |
576.83 | 233.06 | 0.00 |
cerebellum, adult, donor10252 | 10166-103B4 |
293.58 | 232.30 | 2.35 |
cerebellum, adult, pool1 | 10083-102B2 |
246.64 | 103.14 | 1.03 |
cerebellum, newborn, donor10223 | 10357-105E6 |
363.67 | 127.86 | 1.66 |
cerebral meninges, adult | 10188-103D8 |
309.12 | 88.00 | 0.25 |
cerebrospinal fluid, donor2 | 10294-104G6 |
169.57 | 89.17 | 0.73 |
cervical cancer cell line:D98-AH2 | 10552-107I3 |
228.90 | 172.54 | 0.58 |
cervical cancer cell line:ME-180 | 10553-107I4 |
242.94 | 275.26 | 0.17 |
cervix, adult, pool1 | 10013-101C4 |
191.71 | 189.61 | 1.15 |
cholangiocellular carcinoma cell line:HuH-28 | 10536-107G5 |
131.26 | 170.69 | 0.28 |
chondrosarcoma cell line:SW 1353 | 10700-109G7 |
168.51 | 101.89 | 0.00 |
choriocarcinoma cell line:BeWo | 10423-106C9 |
440.68 | 358.66 | 2.61 |
choriocarcinoma cell line:SCH | 10785-110H2 |
329.84 | 267.86 | 0.74 |
choriocarcinoma cell line:T3M-3 | 10618-108G6 |
254.49 | 217.26 | 1.90 |
chorionic membrane cells, donor1 | 12238-129G6 |
141.32 | 132.49 | 0.28 |
chorionic membrane cells, donor2 | 12239-129G7 |
178.98 | 143.78 | 0.40 |
chorionic membrane cells, donor3 | 12240-129G8 |
233.53 | 179.13 | 0.55 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 10416-106C2 |
322.13 | 197.92 | 1.01 |
chronic myeloblastic leukemia (CML) cell line:KCL-22 | 10801-110I9 |
416.85 | 241.47 | 0.96 |
chronic myelogenous leukemia (CML) cell line:MEG-A2 | 10766-110F1 |
459.96 | 253.63 | 0.63 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1 | 10824-111C5 |
401.38 | 123.78 | 0.51 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2 | 10825-111C6 |
418.45 | 155.77 | 0.24 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3 | 10826-111C7 |
409.26 | 146.80 | 0.41 |
chronic myelogenous leukemia cell line:K562 | 10454-106G4 |
359.53 | 178.15 | 1.47 |
chronic myelogenous leukemia cell line:KU812 | 10409-106B4 |
400.58 | 274.44 | 0.00 |
clear cell carcinoma cell line:JHOC-5 | 10638-108I8 |
258.98 | 151.55 | 0.00 |
clear cell carcinoma cell line:TEN | 10636-108I6 |
150.43 | 106.01 | 0.17 |
colon carcinoma cell line:CACO-2 | 10513-107D9 |
195.49 | 163.27 | 1.65 |
colon carcinoma cell line:COLO-320 | 10420-106C6 |
466.36 | 394.90 | 2.66 |
colon, adult, donor1 | 10082-102B1 |
257.05 | 135.66 | 1.19 |
colon, adult, pool1 | 10014-101C5 |
167.32 | 150.76 | 0.35 |
colon, fetal, donor1 | 10070-101I7 |
253.99 | 182.92 | 1.85 |
common myeloid progenitor CMP, donor1 | 12130-128D6 |
334.60 | 105.42 | 0.00 |
common myeloid progenitor CMP, donor2 | 12134-128E1 |
375.55 | 375.55 | 0.00 |
cord blood derived cell line:COBL-a 24h infection(-C) | 10452-106G2 |
247.74 | 217.14 | 0.42 |
cord blood derived cell line:COBL-a 24h infection | 10453-106G3 |
299.00 | 230.77 | 1.96 |
cord blood derived cell line:COBL-a untreated | 10449-106F8 |
333.35 | 253.82 | 2.26 |
corpus callosum, adult, pool1 | 10042-101F6 |
234.06 | 202.88 | 0.44 |
cruciate ligament, donor2 | 10295-104G7 |
262.59 | 118.33 | 1.62 |
diaphragm, fetal, donor1 | 10069-101I6 |
199.84 | 162.12 | 1.61 |
diencephalon, adult | 10193-103E4 |
216.47 | 133.19 | 0.00 |
diffuse large B-cell lymphoma cell line:CTB-1 | 10631-108I1 |
509.74 | 325.59 | 1.38 |
ductal cell carcinoma cell line:KLM-1 | 10438-106E6 |
275.93 | 253.36 | 1.03 |
ductal cell carcinoma cell line:MIA Paca2 | 10488-107B2 |
239.04 | 103.51 | 0.72 |
ductus deferens, adult | 10196-103E7 |
223.75 | 165.95 | 0.50 |
duodenum, fetal, donor1, tech_rep1 | 10071-101I8 |
288.05 | 214.59 | 0.00 |
duodenum, fetal, donor1, tech_rep2 | 10071-101I8 |
297.94 | 228.05 | 2.94 |
dura mater, adult, donor1 | 10041-101F5 |
207.95 | 159.89 | 0.83 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr | 10451-106G1 |
128.14 | 115.48 | 0.89 |
embryonic kidney cell line: HEK293/SLAM untreated | 10450-106F9 |
216.52 | 167.08 | 1.15 |
embryonic pancreas cell line:1B2C6 | 10604-108F1 |
323.72 | 191.15 | 0.00 |
embryonic pancreas cell line:1C3D3 | 10605-108F2 |
219.16 | 194.95 | 0.91 |
embryonic pancreas cell line:1C3IKEI | 10606-108F3 |
311.84 | 271.39 | 0.00 |
embryonic pancreas cell line:2C6 | 10603-108E9 |
312.60 | 294.22 | 0.00 |
endometrial carcinoma cell line:OMC-2 | 10497-107C2 |
167.60 | 141.45 | 1.68 |
endometrial stromal sarcoma cell line:OMC-9 | 10448-106F7 |
132.85 | 221.29 | 0.00 |
endometrioid adenocarcinoma cell line:JHUEM-1 | 10643-109A4 |
200.37 | 170.94 | 0.16 |
epidermoid carcinoma cell line:A431 | 10426-106D3 |
280.34 | 125.83 | 0.11 |
epidermoid carcinoma cell line:Ca Ski | 10431-106D8 |
297.51 | 180.05 | 0.66 |
epididymis, adult | 10197-103E8 |
206.38 | 124.96 | 0.84 |
epithelioid sarcoma cell line:HS-ES-1 | 10443-106F2 |
198.34 | 143.88 | 0.53 |
epithelioid sarcoma cell line:HS-ES-2R | 10495-107B9 |
206.85 | 88.09 | 0.39 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1 | 10815-111B5 |
337.32 | 319.76 | 1.44 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2 | 10816-111B6 |
316.13 | 297.03 | 0.69 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3 | 10817-111B7 |
343.03 | 317.27 | 1.23 |
esophagus, adult, pool1 | 10015-101C6 |
172.75 | 134.00 | 0.11 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS | 10410-106B5 |
350.66 | 299.81 | 0.50 |
eye - muscle inferior rectus, donor1 | 10272-104E2 |
289.75 | 79.68 | 0.00 |
eye - muscle lateral, donor2 | 10298-104H1 |
218.84 | 122.04 | 0.00 |
eye - muscle medial, donor2 | 10299-104H2 |
203.89 | 65.48 | 1.49 |
eye - muscle superior, donor2 | 10297-104G9 |
267.13 | 106.62 | 1.15 |
eye - vitreous humor, donor1 | 10268-104D7 |
199.66 | 99.10 | 0.00 |
eye, fetal, donor1 | 10054-101G9 |
223.47 | 215.08 | 0.25 |
fibrosarcoma cell line:HT-1080 | 10758-110E2 |
200.67 | 172.59 | 0.00 |
fibrous histiocytoma cell line:GCT TIB-223 | 10711-109H9 |
304.13 | 165.48 | 1.19 |
frontal lobe, adult, pool1 | 10040-101F4 |
233.34 | 145.61 | 0.28 |
gall bladder carcinoma cell line:TGBC14TKB | 10470-106I2 |
368.41 | 277.13 | 1.50 |
gall bladder carcinoma cell line:TGBC2TKB | 10415-106C1 |
122.07 | 120.15 | 0.09 |
gall bladder, adult | 10198-103E9 |
186.39 | 115.65 | 1.21 |
gamma delta positive T cells, donor1 | 11937-126A2 |
278.63 | 229.77 | 7.52 |
gamma delta positive T cells, donor2 | 11938-126A3 |
256.96 | 211.40 | 6.72 |
gastric adenocarcinoma cell line:MKN1 | 10614-108G2 |
262.12 | 179.11 | 0.00 |
gastric adenocarcinoma cell line:MKN45 | 10612-108F9 |
201.35 | 141.00 | 0.19 |
gastric cancer cell line:AZ521 | 10549-107H9 |
271.18 | 247.57 | 1.15 |
gastric cancer cell line:GSS | 10560-108A2 |
239.79 | 143.69 | 1.83 |
gastrointestinal carcinoma cell line:ECC12 | 10615-108G3 |
302.25 | 248.56 | 3.20 |
giant cell carcinoma cell line:LU65 | 10487-107B1 |
150.88 | 120.48 | 0.69 |
giant cell carcinoma cell line:Lu99B | 10433-106E1 |
283.28 | 164.73 | 0.70 |
glassy cell carcinoma cell line:HOKUG | 10688-109F4 |
256.15 | 189.06 | 0.50 |
glioblastoma cell line:A172, tech_rep1 | 10444-106F3 |
175.22 | 114.74 | 0.74 |
glioblastoma cell line:A172, tech_rep2 | 10444-106F3 |
182.71 | 136.93 | 0.98 |
glioblastoma cell line:T98G | 10485-107A8 |
213.35 | 201.10 | 0.22 |
glioma cell line:GI-1 | 10413-106B8 |
161.38 | 132.09 | 0.29 |
globus pallidus - adult, donor10196 | 10175-103C4 |
383.41 | 155.99 | 0.73 |
globus pallidus, adult, donor10252 | 10161-103A8 |
269.24 | 216.76 | 1.95 |
globus pallidus, adult, donor10258 | 10367-105F7 |
320.39 | 130.07 | 2.74 |
globus pallidus, newborn, donor10223 | 10364-105F4 |
208.90 | 61.29 | 1.07 |
granulocyte macrophage progenitor, donor1 | 12131-128D7 |
320.58 | 41.60 | 4.89 |
granulocyte macrophage progenitor, donor2 | 12135-128E2 |
305.99 | 295.07 | 0.00 |
granulocyte macrophage progenitor, donor3 | 12139-128E6 |
235.20 | 156.80 | 0.00 |
granulosa cell tumor cell line:KGN | 10624-108H3 |
189.44 | 139.52 | 0.32 |
hIPS +CCl2, biol_rep1 | 14383-156B9 |
472.43 | 173.09 | 0.46 |
hIPS +CCl2, biol_rep2 | 14384-156C1 |
395.53 | 144.04 | 0.00 |
hIPS +CCl2, biol_rep3 | 14385-156C2 |
399.98 | 130.75 | 0.00 |
hIPS, biol_rep1 | 14380-156B6 |
557.67 | 171.04 | 0.00 |
hIPS, biol_rep2 | 14381-156B7 |
443.07 | 131.69 | 0.69 |
hIPS, biol_rep3 | 14382-156B8 |
232.83 | 100.42 | 0.00 |
hairy cell leukemia cell line:Mo | 10712-109I1 |
354.87 | 180.45 | 0.86 |
heart - mitral valve, adult | 10205-103F7 |
213.46 | 122.28 | 0.60 |
heart - pulmonic valve, adult | 10206-103F8 |
196.63 | 116.36 | 0.00 |
heart - tricuspid valve, adult | 10207-103F9 |
306.41 | 117.40 | 5.83 |
heart, adult, diseased post-infarction, donor1 | 10050-101G5 |
208.55 | 187.12 | 0.41 |
heart, adult, diseased, donor1 | 10051-101G6 |
221.86 | 192.90 | 0.00 |
heart, adult, pool1 | 10016-101C7 |
114.07 | 88.31 | 0.23 |
heart, fetal, pool1 | 10046-101G1 |
230.82 | 236.57 | 0.51 |
hepatic mesenchymal tumor cell line:LI90 | 10778-110G4 |
138.22 | 123.10 | 0.00 |
hepatoblastoma cell line:HuH-6 | 10633-108I3 |
475.67 | 192.65 | 2.38 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1 | 10818-111B8 |
441.98 | 253.26 | 1.44 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2 | 10819-111B9 |
433.55 | 270.54 | 0.97 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3 | 10820-111C1 |
431.30 | 280.73 | 1.31 |
hepatoma cell line:Li-7 | 10484-107A7 |
238.67 | 194.18 | 0.78 |
hereditary spherocytic anemia cell line:WIL2-NS | 10808-111A7 |
441.90 | 271.35 | 0.00 |
hippocampus - adult, donor10196 | 10169-103B7 |
321.75 | 141.00 | 0.00 |
hippocampus, adult, donor10252 | 10153-102I9 |
219.20 | 196.75 | 1.02 |
hippocampus, adult, donor10258 | 10374-105G5 |
246.98 | 67.22 | 0.00 |
hippocampus, newborn, donor10223 | 10363-105F3 |
217.13 | 49.70 | 0.70 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1 | 13421-144D1 |
907.58 | 322.87 | 9.16 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2 | 13425-144D5 |
422.16 | 162.19 | 3.93 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3 | 13429-144D9 |
506.78 | 181.79 | 5.08 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1 | 13422-144D2 |
543.00 | 197.92 | 1.69 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2 | 13426-144D6 |
476.14 | 248.14 | 2.84 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3 | 13430-144E1 |
543.60 | 217.14 | 3.04 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1 | 13423-144D3 |
454.86 | 202.91 | 1.75 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2 | 13427-144D7 |
355.46 | 172.99 | 3.02 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3 | 13431-144E2 |
415.82 | 181.43 | 3.34 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1 | 13424-144D4 |
315.64 | 210.51 | 0.95 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2 | 13428-144D8 |
390.38 | 229.02 | 1.61 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3 | 13432-144E3 |
334.63 | 206.03 | 0.67 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1 | 13433-144E4 |
365.55 | 173.54 | 4.23 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 13437-144E8 |
445.11 | 208.80 | 3.93 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3 | 13441-144F3 |
583.87 | 279.28 | 7.85 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1 | 13434-144E5 |
549.82 | 267.66 | 2.67 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 13438-144E9 |
495.81 | 222.40 | 1.74 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3 | 13442-144F4 |
776.13 | 296.36 | 3.50 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1 | 13435-144E6 |
265.44 | 126.98 | 2.83 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 13439-144F1 |
283.74 | 143.69 | 2.27 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3 | 13443-144F5 |
328.58 | 115.90 | 3.13 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1 | 13436-144E7 |
312.89 | 190.41 | 1.96 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2 | 13440-144F2 |
297.57 | 170.12 | 1.74 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3 | 13444-144F6 |
407.43 | 155.44 | 0.90 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1 | 13445-144F7 |
427.87 | 168.49 | 4.99 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 13449-144G2 |
374.58 | 152.34 | 4.28 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3 | 13453-144G6 |
621.86 | 211.91 | 6.12 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 13446-144F8 |
403.84 | 201.74 | 2.11 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 13450-144G3 |
333.21 | 128.28 | 0.95 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 13454-144G7 |
392.50 | 140.42 | 1.82 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1 | 13447-144F9 |
303.03 | 107.04 | 1.03 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 13451-144G4 |
292.23 | 103.61 | 1.99 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 13455-144G8 |
343.50 | 101.07 | 0.77 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 13448-144G1 |
330.30 | 162.34 | 0.51 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2 | 13452-144G5 |
428.59 | 159.77 | 0.00 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 13456-144G9 |
407.64 | 147.19 | 1.68 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 13457-144H1 |
372.40 | 128.48 | 3.14 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 13461-144H5 |
478.19 | 135.93 | 7.58 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3 | 13465-144H9 |
488.78 | 140.98 | 6.34 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 13458-144H2 |
408.92 | 167.48 | 3.06 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2 | 13462-144H6 |
2368.36 | 1350.10 | 22.77 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3 | 13466-144I1 |
626.14 | 253.17 | 3.97 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 13459-144H3 |
335.49 | 129.71 | 0.55 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 13463-144H7 |
374.19 | 120.51 | 1.45 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3 | 13467-144I2 |
321.00 | 117.08 | 0.71 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1 | 13460-144H4 |
362.79 | 131.27 | 1.19 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2 | 13464-144H8 |
354.81 | 205.98 | 0.81 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3 | 13468-144I3 |
409.48 | 129.85 | 1.62 |
immature langerhans cells, donor1 | 11904-125F5 |
384.53 | 219.87 | 3.15 |
immature langerhans cells, donor2 | 11905-125F6 |
258.24 | 111.69 | 4.75 |
insula, adult, pool1 | 10039-101F3 |
252.67 | 144.22 | 0.57 |
keratoacanthoma cell line:HKA-1 | 10791-110H8 |
218.17 | 216.55 | 1.30 |
kidney, adult, pool1 | 10017-101C8 |
140.08 | 160.60 | 1.00 |
kidney, fetal, pool1 | 10045-101F9 |
208.46 | 205.42 | 0.42 |
large cell lung carcinoma cell line:IA-LM | 10509-107D5 |
241.29 | 227.23 | 0.71 |
large cell lung carcinoma cell line:NCI-H460 | 10839-111E2 |
159.81 | 124.97 | 0.55 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 10692-109F8 |
192.49 | 160.75 | 0.92 |
left atrium, adult, donor1 | 10079-102A7 |
180.89 | 125.86 | 0.00 |
left ventricle, adult, donor1 | 10078-102A6 |
225.52 | 123.38 | 0.00 |
leiomyoblastoma cell line:G-402 | 10721-110A1 |
451.18 | 199.46 | 0.55 |
leiomyoma cell line:10964C | 10569-108B2 |
105.26 | 52.09 | 0.00 |
leiomyoma cell line:15242A | 10570-108B3 |
95.11 | 47.83 | 0.00 |
leiomyoma cell line:15425 | 10571-108B4 |
141.56 | 92.27 | 0.00 |
leiomyosarcoma cell line:Hs 5.T | 10722-110A2 |
158.73 | 38.10 | 0.00 |
lens epithelial cell line:SRA 01/04 | 10647-109A8 |
172.52 | 148.47 | 0.00 |
leukemia, chronic megakaryoblastic cell line:MEG-01 | 10752-110D5 |
349.57 | 188.89 | 1.06 |
liposarcoma cell line:KMLS-1 | 10782-110G8 |
175.11 | 124.66 | 0.00 |
liposarcoma cell line:SW 872 | 10726-110A6 |
300.70 | 242.58 | 0.37 |
liver, adult, pool1 | 10018-101C9 |
152.18 | 165.95 | 0.16 |
liver, fetal, pool1 | 10086-102B5 |
189.08 | 110.06 | 0.00 |
locus coeruleus - adult, donor10196 | 10182-103D2 |
268.75 | 104.56 | 0.58 |
locus coeruleus, adult, donor10252 | 10165-103B3 |
215.37 | 174.03 | 0.55 |
locus coeruleus, adult, donor10258 | 10375-105G6 |
159.69 | 106.37 | 0.00 |
locus coeruleus, newborn, donor10223 | 10362-105F2 |
244.38 | 148.90 | 1.26 |
lung adenocarcinoma cell line:A549 | 10499-107C4 |
121.79 | 99.23 | 0.14 |
lung adenocarcinoma cell line:PC-14 | 10408-106B3 |
208.20 | 173.04 | 0.00 |
lung adenocarcinoma, papillary cell line:NCI-H441 | 10742-110C4 |
299.88 | 138.93 | 0.40 |
lung, adult, pool1 | 10019-101D1 |
192.78 | 126.28 | 0.59 |
lung, fetal, donor1 | 10068-101I5 |
356.76 | 282.55 | 2.00 |
lung, right lower lobe, adult, donor1 | 10075-102A3 |
223.15 | 176.87 | 1.83 |
lymph node, adult, donor1 | 10077-102A5 |
253.25 | 184.14 | 0.00 |
lymphangiectasia cell line:DS-1 | 10727-110A7 |
277.48 | 215.45 | 0.44 |
lymphoma, malignant, hairy B-cell cell line:MLMA | 10775-110G1 |
252.95 | 258.54 | 1.51 |
malignant trichilemmal cyst cell line:DJM-1 | 10412-106B7 |
288.83 | 253.15 | 1.70 |
mature adipocyte, donor1 | 12231-129F8 |
101.23 | 129.20 | 0.00 |
mature adipocyte, donor2 | 12232-129F9 |
104.59 | 124.10 | 0.62 |
mature adipocyte, donor3 | 12233-129G1 |
112.84 | 142.71 | 0.24 |
mature adipocyte, donor4 | 12234-129G2 |
109.50 | 154.51 | 0.26 |
maxillary sinus tumor cell line:HSQ-89 | 10414-106B9 |
242.79 | 264.71 | 1.91 |
medial frontal gyrus - adult, donor10196 | 10170-103B8 |
332.77 | 152.28 | 0.00 |
medial frontal gyrus, adult, donor10252 | 10150-102I6 |
229.33 | 183.17 | 0.92 |
medial frontal gyrus, adult, donor10258 | 10368-105F8 |
302.44 | 105.47 | 0.64 |
medial frontal gyrus, newborn, donor10223 | 10352-105E1 |
406.87 | 117.71 | 0.85 |
medial temporal gyrus - adult, donor10196 | 10183-103D3 |
352.69 | 166.89 | 0.34 |
medial temporal gyrus, adult, donor10252 | 10156-103A3 |
245.97 | 186.97 | 1.06 |
medial temporal gyrus, adult, donor10258, tech_rep1 | 10376-105G7 |
333.24 | 111.72 | 0.00 |
medial temporal gyrus, adult, donor10258, tech_rep2 | 10376-105G7 |
617.21 | 301.43 | 28.71 |
medial temporal gyrus, newborn, donor10223 | 10353-105E2 |
239.41 | 54.20 | 0.72 |
medulla oblongata - adult, donor10196 | 10174-103C3 |
282.31 | 171.33 | 0.00 |
medulla oblongata, adult, donor10252 | 10155-103A2 |
209.14 | 199.85 | 0.31 |
medulla oblongata, adult, pool1 | 10038-101F2 |
167.42 | 143.01 | 0.73 |
medulla oblongata, newborn, donor10223 | 10361-105F1 |
175.67 | 84.36 | 0.69 |
medulloblastoma cell line:D283 Med | 10838-111E1 |
518.77 | 236.69 | 0.22 |
medulloblastoma cell line:ONS-76 | 10759-110E3 |
346.15 | 192.58 | 0.49 |
melanoma cell line:COLO 679 | 10514-107E1 |
209.15 | 191.47 | 0.57 |
melanoma cell line:G-361 | 10465-106H6 |
214.18 | 178.62 | 0.27 |
meningioma cell line:HKBMM | 10691-109F7 |
179.82 | 136.94 | 0.54 |
merkel cell carcinoma cell line:MKL-1 | 10843-111E6 |
727.84 | 385.07 | 6.17 |
merkel cell carcinoma cell line:MS-1 | 10844-111E7 |
545.41 | 290.07 | 1.04 |
mesenchymal precursor cell - adipose, donor1 | 11747-123G1 |
212.20 | 129.50 | 0.00 |
mesenchymal precursor cell - adipose, donor2 | 11748-123G2 |
139.61 | 76.35 | 0.55 |
mesenchymal precursor cell - adipose, donor3 | 11749-123G3 |
144.94 | 108.08 | 0.00 |
mesenchymal precursor cell - bone marrow, donor1 | 11750-123G4 |
118.84 | 89.34 | 0.28 |
mesenchymal precursor cell - bone marrow, donor2 | 11751-123G5 |
113.23 | 79.15 | 0.39 |
mesenchymal precursor cell - bone marrow, donor3 | 11840-124H4 |
136.73 | 75.65 | 0.00 |
mesenchymal precursor cell - cardiac, donor1 | 11752-123G6 |
85.99 | 70.37 | 0.00 |
mesenchymal precursor cell - cardiac, donor2 | 11753-123G7 |
116.05 | 97.53 | 0.23 |
mesenchymal precursor cell - cardiac, donor3 | 11754-123G8 |
167.26 | 117.38 | 0.27 |
mesenchymal precursor cell - cardiac, donor4 | 11755-123G9 |
173.80 | 98.98 | 0.54 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1 | 11756-123H1 |
174.13 | 120.64 | 0.28 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 11833-124G6 |
133.72 | 74.76 | 0.66 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 11760-123H5 |
179.47 | 117.75 | 0.42 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4 | 11836-124G9 |
178.73 | 104.03 | 0.35 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1 | 11758-123H3 |
119.84 | 84.73 | 0.00 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2 | 11835-124G8 |
136.95 | 55.00 | 0.72 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3 | 11762-123H7 |
89.38 | 82.24 | 0.00 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4 | 11838-124H2 |
94.16 | 54.03 | 0.68 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1 | 11757-123H2 |
255.51 | 154.82 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 11759-123H4 |
148.99 | 113.72 | 0.15 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02) | 11761-123H6 |
140.75 | 106.17 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G) | 11842-124H6 |
128.86 | 78.42 | 0.00 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4 | 11837-124H1 |
132.20 | 65.24 | 0.29 |
mesenchymal stem cell line:Hu5/E18 | 10568-108B1 |
309.02 | 214.30 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 13229-141I7 |
137.91 | 100.01 | 0.91 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2 | 13230-141I8 |
134.80 | 111.78 | 0.51 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3 | 13231-141I9 |
146.32 | 111.51 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1 | 13232-142A1 |
146.96 | 96.43 | 0.92 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2 | 13233-142A2 |
136.27 | 114.62 | 0.94 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3 | 13234-142A3 |
155.01 | 118.80 | 0.68 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1 | 13235-142A4 |
146.19 | 106.50 | 1.18 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2 | 13236-142A5 |
149.67 | 85.73 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3 | 13237-142A6 |
338.13 | 241.52 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1 | 13238-142A7 |
185.74 | 132.10 | 0.29 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2 | 13239-142A8 |
141.45 | 112.67 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3 | 13240-142A9 |
155.03 | 115.85 | 0.48 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1 | 13241-142B1 |
211.93 | 129.07 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2 | 13242-142B2 |
146.01 | 91.30 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3 | 13243-142B3 |
132.64 | 106.85 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 13244-142B4 |
157.22 | 117.27 | 0.43 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 13245-142B5 |
202.35 | 68.36 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3 | 13246-142B6 |
175.61 | 82.64 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1 | 13247-142B7 |
180.58 | 97.11 | 1.30 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2 | 13248-142B8 |
133.86 | 80.02 | 1.45 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3 | 13249-142B9 |
200.97 | 92.22 | 1.07 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 13250-142C1 |
149.65 | 66.24 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2 | 13251-142C2 |
176.87 | 84.74 | 0.78 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3 | 13252-142C3 |
167.90 | 96.54 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1 | 13253-142C4 |
152.00 | 57.62 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2 | 13254-142C5 |
123.95 | 85.81 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3 | 13255-142C6 |
167.81 | 97.84 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1 | 13256-142C7 |
148.65 | 76.76 | 1.22 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2 | 13257-142C8 |
162.31 | 81.16 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3 | 13258-142C9 |
169.75 | 90.57 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1 | 13259-142D1 |
147.62 | 98.99 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2 | 13260-142D2 |
107.46 | 77.37 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3 | 13261-142D3 |
123.75 | 83.83 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1 | 13262-142D4 |
92.98 | 61.99 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2 | 13263-142D5 |
97.79 | 68.05 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3 | 13264-142D6 |
96.13 | 70.71 | 0.79 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1 | 13265-142D7 |
77.82 | 71.33 | 0.59 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2 | 13266-142D8 |
107.54 | 85.72 | 0.94 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3 | 13267-142D9 |
92.23 | 80.20 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1 | 13268-142E1 |
132.46 | 94.61 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2 | 13269-142E2 |
102.72 | 112.99 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3 | 13270-142E3 |
136.99 | 97.06 | 0.69 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1 | 13271-142E4 |
95.50 | 88.57 | 0.99 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2 | 13272-142E5 |
85.23 | 61.68 | 1.12 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3 | 13273-142E6 |
107.49 | 88.41 | 0.64 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1 | 13274-142E7 |
112.84 | 80.19 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2 | 13275-142E8 |
85.04 | 61.06 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3 | 13276-142E9 |
87.43 | 74.76 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 13277-142F1 |
95.89 | 86.78 | 0.61 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2 | 13278-142F2 |
67.78 | 99.42 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3 | 13279-142F3 |
88.96 | 64.25 | 0.00 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1 | 13280-142F4 |
82.35 | 78.78 | 0.40 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2 | 13281-142F5 |
108.06 | 91.83 | 0.00 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3 | 13282-142F6 |
101.86 | 81.49 | 1.02 |
mesodermal tumor cell line:HIRS-BM | 10696-109G3 |
146.23 | 109.87 | 0.77 |
mesothelioma cell line:ACC-MESO-1 | 10493-107B7 |
127.81 | 173.87 | 0.24 |
mesothelioma cell line:ACC-MESO-4 | 10494-107B8 |
242.56 | 170.05 | 0.23 |
mesothelioma cell line:Mero-14, tech_rep1 | 10849-111F3 |
209.41 | 85.47 | 4.27 |
mesothelioma cell line:Mero-14, tech_rep2 | 10849-111F3 |
245.88 | 219.58 | 0.10 |
mesothelioma cell line:Mero-25 | 10850-111F4 |
195.86 | 122.33 | 0.45 |
mesothelioma cell line:Mero-41 | 10851-111F5 |
270.63 | 140.57 | 0.73 |
mesothelioma cell line:Mero-48a | 10852-111F6 |
259.30 | 110.72 | 0.00 |
mesothelioma cell line:Mero-82 | 10853-111F7 |
293.29 | 163.46 | 1.31 |
mesothelioma cell line:Mero-83 | 10854-111F8 |
272.35 | 145.37 | 0.00 |
mesothelioma cell line:Mero-84 | 10855-111F9 |
232.55 | 156.72 | 0.51 |
mesothelioma cell line:Mero-95 | 10856-111G1 |
259.01 | 185.10 | 0.41 |
mesothelioma cell line:NCI-H2052 | 10847-111F1 |
220.15 | 135.50 | 0.33 |
mesothelioma cell line:NCI-H226 | 10846-111E9 |
248.32 | 127.60 | 0.54 |
mesothelioma cell line:NCI-H2452 | 10848-111F2 |
180.22 | 88.66 | 0.17 |
mesothelioma cell line:NCI-H28 | 10845-111E8 |
265.15 | 183.47 | 1.02 |
mesothelioma cell line:No36 | 10857-111G2 |
180.39 | 113.19 | 0.33 |
mesothelioma cell line:ONE58 | 10858-111G3 |
221.10 | 140.08 | 0.81 |
migratory langerhans cells, donor1 | 11901-125F2 |
250.84 | 172.73 | 1.73 |
migratory langerhans cells, donor2 | 11902-125F3 |
186.96 | 137.01 | 0.49 |
migratory langerhans cells, donor3 | 11903-125F4 |
235.30 | 136.23 | 0.90 |
mixed mullerian tumor cell line:HTMMT | 10689-109F5 |
279.14 | 192.95 | 1.31 |
mucinous adenocarcinoma cell line:JHOM-1 | 10648-109A9 |
206.00 | 140.30 | 0.21 |
mucinous cystadenocarcinoma cell line:MCAS | 10784-110H1 |
359.13 | 158.72 | 0.23 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 10744-110C6 |
263.75 | 166.70 | 0.95 |
myelodysplastic syndrome cell line:SKM-1 | 10772-110F7 |
296.96 | 247.62 | 0.74 |
myeloma cell line:PCM6 | 10474-106I6 |
161.89 | 204.19 | 0.00 |
myxofibrosarcoma cell line:MFH-ino | 10600-108E6 |
371.34 | 136.46 | 0.00 |
myxofibrosarcoma cell line:NMFH-1 | 10684-109E9 |
203.59 | 117.10 | 0.59 |
nasal epithelial cells, donor1, tech_rep1 | 12226-129F3 |
80.78 | 62.40 | 0.22 |
nasal epithelial cells, donor1, tech_rep2 | 12226-129F3 |
87.51 | 60.89 | 0.51 |
nasal epithelial cells, donor2 | 12227-129F4 |
114.26 | 167.25 | 0.00 |
neuroblastoma cell line:CHP-134 | 10508-107D4 |
466.33 | 359.82 | 8.51 |
neuroblastoma cell line:NB-1 | 10539-107G8 |
485.30 | 294.66 | 1.87 |
neuroblastoma cell line:NBsusSR | 10607-108F4 |
254.33 | 213.63 | 0.21 |
neuroblastoma cell line:NH-12 | 10555-107I6 |
568.18 | 294.99 | 3.17 |
neuroectodermal tumor cell line:FU-RPNT-1 | 10637-108I7 |
397.12 | 180.77 | 4.98 |
neuroectodermal tumor cell line:FU-RPNT-2 | 10663-109C6 |
392.63 | 227.28 | 2.69 |
neuroectodermal tumor cell line:TASK1 | 10774-110F9 |
248.96 | 129.21 | 0.20 |
neuroepithelioma cell line:SK-N-MC | 10728-110A8 |
512.43 | 184.37 | 0.64 |
neurofibroma cell line:Hs 53.T | 10729-110A9 |
215.33 | 141.60 | 0.27 |
neutrophil PMN, donor1 | 12133-128D9 |
89.25 | 14.87 | 0.00 |
neutrophil PMN, donor2 | 12137-128E4 |
252.33 | 185.93 | 0.00 |
neutrophil PMN, donor3 | 12141-128E8 |
227.30 | 104.18 | 0.00 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK | 10430-106D7 |
677.83 | 371.73 | 1.18 |
non-small cell lung cancer cell line:NCI-H1385 | 10730-110B1 |
252.96 | 93.66 | 0.80 |
normal embryonic palatal mesenchymal cell line:HEPM | 10813-111B3 |
143.95 | 127.60 | 0.32 |
normal intestinal epithelial cell line:FHs 74 Int | 10812-111B2 |
185.77 | 104.84 | 0.26 |
nucleus accumbens, adult, pool1 | 10037-101F1 |
217.85 | 145.01 | 0.75 |
occipital cortex - adult, donor10196 | 10172-103C1 |
401.77 | 160.71 | 0.00 |
occipital cortex, adult, donor10252 | 10163-103B1 |
275.61 | 180.34 | 2.68 |
occipital cortex, newborn, donor10223 | 10355-105E4 |
279.14 | 49.13 | 0.73 |
occipital lobe, adult, donor1 | 10076-102A4 |
336.92 | 166.10 | 0.26 |
occipital lobe, fetal, donor1 | 10073-102A1 |
658.67 | 262.61 | 0.86 |
occipital pole, adult, pool1 | 10036-101E9 |
177.08 | 99.50 | 0.16 |
olfactory region, adult | 10195-103E6 |
236.33 | 104.51 | 0.38 |
optic nerve, donor1 | 10277-104E7 |
466.24 | 100.05 | 2.00 |
oral squamous cell carcinoma cell line:Ca9-22 | 10434-106E2 |
319.40 | 199.11 | 0.91 |
oral squamous cell carcinoma cell line:HO-1-u-1 | 10550-107I1 |
222.43 | 143.71 | 0.41 |
oral squamous cell carcinoma cell line:HSC-3 | 10545-107H5 |
301.90 | 216.90 | 0.68 |
oral squamous cell carcinoma cell line:SAS | 10544-107H4 |
307.72 | 212.77 | 0.58 |
osteoclastoma cell line:Hs 706.T | 10704-109H2 |
188.43 | 137.87 | 0.29 |
osteosarcoma cell line:143B/TK^(-)neo^(R) | 10510-107D6 |
414.84 | 312.07 | 0.93 |
osteosarcoma cell line:HS-Os-1 | 10558-107I9 |
258.50 | 175.58 | 1.48 |
ovary, adult, pool1 | 10020-101D2 |
168.06 | 160.46 | 0.44 |
pagetoid sarcoma cell line:Hs 925.T | 10732-110B3 |
230.43 | 106.88 | 0.18 |
pancreas, adult, donor1 | 10049-101G4 |
211.64 | 206.00 | 0.00 |
pancreatic carcinoma cell line:NOR-P1 | 10698-109G5 |
302.18 | 213.29 | 1.68 |
papillary adenocarcinoma cell line:8505C | 10437-106E5 |
248.20 | 212.94 | 0.85 |
papillotubular adenocarcinoma cell line:TGBC18TKB | 10417-106C3 |
224.20 | 184.13 | 0.99 |
paracentral gyrus, adult, pool1 | 10035-101E8 |
196.96 | 135.00 | 0.64 |
parietal cortex, adult, donor10258 | 10373-105G4 |
206.99 | 145.33 | 0.00 |
parietal lobe - adult, donor10196 | 10171-103B9 |
343.28 | 126.02 | 0.00 |
parietal lobe, adult, donor10252 | 10157-103A4 |
228.31 | 176.15 | 0.57 |
parietal lobe, adult, pool1 | 10034-101E7 |
211.13 | 130.33 | 0.26 |
parietal lobe, fetal, donor1 | 10072-101I9 |
670.16 | 420.91 | 1.94 |
parietal lobe, newborn, donor10223 | 10356-105E5 |
268.81 | 62.06 | 0.00 |
parotid gland, adult | 10199-103F1 |
139.37 | 205.35 | 0.00 |
penis, adult | 10200-103F2 |
188.53 | 130.52 | 0.00 |
peripheral neuroectodermal tumor cell line:KU-SN | 10697-109G4 |
508.91 | 162.69 | 3.16 |
pharyngeal carcinoma cell line:Detroit 562 | 10723-110A3 |
264.87 | 210.38 | 0.29 |
pineal gland - adult, donor10196 | 10179-103C8 |
356.06 | 136.75 | 0.00 |
pineal gland, adult, donor10252 | 10160-103A7 |
220.90 | 257.61 | 0.59 |
pineal gland, adult, donor10258 | 10377-105G8 |
251.46 | 174.95 | 0.00 |
pituitary gland - adult, donor10196 | 10180-103C9 |
373.35 | 283.30 | 0.00 |
pituitary gland, adult, donor10252 | 10162-103A9 |
290.30 | 383.59 | 4.69 |
pituitary gland, adult, donor10258 | 10378-105G9 |
277.50 | 244.31 | 0.00 |
placenta, adult, pool1 | 10021-101D3 |
205.01 | 181.14 | 0.54 |
plasma cell leukemia cell line:ARH-77 | 10840-111E3 |
307.10 | 205.53 | 0.26 |
pleomorphic hepatocellular carcinoma cell line:SNU-387 | 10706-109H4 |
172.92 | 148.17 | 1.40 |
pons, adult, pool1 | 10033-101E6 |
178.85 | 129.36 | 0.43 |
postcentral gyrus, adult, pool1 | 10032-101E5 |
203.03 | 123.35 | 0.52 |
promyelocytes/myelocytes PMC, donor1 | 12132-128D8 |
142.21 | 25.10 | 0.00 |
promyelocytes/myelocytes PMC, donor2 | 12136-128E3 |
214.81 | 192.78 | 0.00 |
promyelocytes/myelocytes PMC, donor3 | 12140-128E7 |
199.51 | 152.56 | 11.74 |
prostate cancer cell line:DU145 | 10490-107B4 |
252.14 | 206.69 | 0.44 |
prostate cancer cell line:PC-3 | 10439-106E7 |
238.13 | 222.34 | 0.18 |
prostate, adult, pool1 | 10022-101D4 |
128.78 | 144.20 | 0.27 |
putamen, adult, donor10196 | 10176-103C5 |
287.76 | 194.04 | 0.00 |
putamen, adult, donor10252 | 10152-102I8 |
180.39 | 54.90 | 0.00 |
putamen, adult, donor10258, tech_rep1 | 10372-105G3 |
324.56 | 115.84 | 0.00 |
putamen, adult, donor10258, tech_rep2 | 10372-105G3 |
206.82 | 84.08 | 0.72 |
putamen, newborn, donor10223 | 10365-105F5 |
235.39 | 173.92 | 3.00 |
rectal cancer cell line:TT1TKB | 10469-106I1 |
188.23 | 162.63 | 0.87 |
rectum, fetal, donor1 | 10067-101I4 |
442.34 | 216.99 | 1.39 |
renal cell carcinoma cell line:OS-RC-2 | 10411-106B6 |
120.20 | 73.99 | 0.00 |
renal cell carcinoma cell line:TUHR10TKB | 10471-106I3 |
119.29 | 91.95 | 2.07 |
retina, adult, pool1 | 10030-101E3 |
166.79 | 170.57 | 0.99 |
retinoblastoma cell line:Y79 | 10475-106I7 |
446.60 | 235.12 | 3.38 |
rhabdomyosarcoma cell line:KYM-1 | 10787-110H4 |
385.57 | 176.92 | 0.37 |
rhabdomyosarcoma cell line:RMS-YM | 10477-106I9 |
415.61 | 241.27 | 1.12 |
sacrococcigeal teratoma cell line:HTST | 10695-109G2 |
223.57 | 111.40 | 0.00 |
salivary acinar cells, donor1 | 11771-123I7 |
189.53 | 85.30 | 0.32 |
salivary acinar cells, donor2 | 11772-123I8 |
200.61 | 102.03 | 0.28 |
salivary acinar cells, donor3 | 11773-123I9 |
172.13 | 91.36 | 0.66 |
salivary gland, adult, pool1 | 10093-102C3 |
116.68 | 160.15 | 2.29 |
schwannoma cell line:HS-PSS, tech_rep1 | 10442-106F1 |
189.36 | 138.78 | 0.17 |
schwannoma cell line:HS-PSS, tech_rep2 | 10442-106F1 |
185.26 | 146.94 | 0.47 |
seminal vesicle, adult | 10201-103F3 |
331.73 | 173.01 | 1.06 |
serous adenocarcinoma cell line:JHOS-2 | 10639-108I9 |
236.37 | 212.80 | 0.49 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1 | 11843-124H7 |
181.18 | 115.50 | 0.75 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1 | 11841-124H5 |
308.08 | 142.50 | 0.00 |
serous cystadenocarcinoma cell line:HTOA | 10693-109F9 |
272.81 | 173.27 | 1.21 |
signet ring carcinoma cell line:Kato III | 10436-106E4 |
207.35 | 182.81 | 0.55 |
signet ring carcinoma cell line:NUGC-4 | 10483-107A6 |
189.02 | 186.96 | 0.39 |
skeletal muscle - soleus muscle, donor1 | 10282-104F3 |
295.08 | 153.22 | 0.71 |
skeletal muscle, adult, pool1 | 10023-101D5 |
138.65 | 156.28 | 0.36 |
skeletal muscle, fetal, donor1 | 10066-101I3 |
222.11 | 171.86 | 1.01 |
skin, adult, donor1 | 10074-102A2 |
223.91 | 149.27 | 13.57 |
skin, fetal, donor1 | 10065-101I2 |
392.62 | 353.49 | 0.63 |
small cell cervical cancer cell line:HCSC-1 | 10800-110I8 |
396.23 | 369.88 | 4.00 |
small cell gastrointestinal carcinoma cell line:ECC10 | 10610-108F7 |
499.60 | 342.31 | 1.58 |
small cell lung carcinoma cell line:DMS 144 | 10841-111E4 |
248.64 | 204.89 | 1.54 |
small cell lung carcinoma cell line:LK-2 | 10541-107H1 |
512.45 | 402.51 | 2.31 |
small cell lung carcinoma cell line:NCI-H82 | 10842-111E5 |
402.61 | 184.49 | 2.90 |
small cell lung carcinoma cell line:WA-hT | 10562-108A4 |
326.22 | 331.02 | 1.53 |
small intestine, adult, pool1 | 10024-101D6 |
198.63 | 187.05 | 0.12 |
small intestine, fetal, donor1 | 10064-101I1 |
331.94 | 262.89 | 0.00 |
small-cell gastrointestinal carcinoma cell line:ECC4 | 10609-108F6 |
282.10 | 118.99 | 1.54 |
smooth muscle, adult, pool1 | 10048-101G3 |
226.41 | 166.70 | 0.52 |
somatostatinoma cell line:QGP-1 | 10781-110G7 |
369.87 | 147.68 | 1.07 |
spinal cord - adult, donor10196 | 10181-103D1 |
342.27 | 208.30 | 0.92 |
spinal cord, adult, donor10252 | 10159-103A6 |
188.07 | 182.15 | 3.15 |
spinal cord, adult, donor10258 | 10369-105F9 |
214.46 | 187.48 | 0.00 |
spinal cord, fetal, donor1 | 10056-101H2 |
308.58 | 210.39 | 0.61 |
spinal cord, newborn, donor10223 | 10359-105E8 |
308.59 | 145.11 | 0.46 |
spindle cell sarcoma cell line:Hs 132.T | 10737-110B8 |
205.51 | 131.43 | 0.30 |
spleen, adult, pool1 | 10025-101D7 |
187.89 | 162.89 | 1.10 |
spleen, fetal, pool1 | 10044-101F8 |
224.54 | 201.50 | 1.03 |
splenic lymphoma with villous lymphocytes cell line:SLVL | 10424-106D1 |
235.59 | 170.28 | 0.72 |
squamous cell carcinoma cell line:EC-GI-10 | 10463-106H4 |
132.15 | 152.28 | 0.95 |
squamous cell carcinoma cell line:JHUS-nk1 | 10646-109A7 |
260.69 | 239.37 | 0.35 |
squamous cell carcinoma cell line:T3M-5 | 10616-108G4 |
282.25 | 127.44 | 1.17 |
squamous cell lung carcinoma cell line:EBC-1 | 10486-107A9 |
257.98 | 222.53 | 0.68 |
squamous cell lung carcinoma cell line:LC-1F | 10457-106G7 |
273.22 | 168.59 | 0.42 |
squamous cell lung carcinoma cell line:RERF-LC-AI | 10501-107C6 |
237.34 | 115.50 | 0.00 |
stomach, fetal, donor1 | 10062-101H8 |
495.54 | 230.68 | 4.27 |
submaxillary gland, adult | 10202-103F4 |
173.75 | 131.60 | 0.00 |
substantia nigra - adult, donor10196 | 10178-103C7 |
325.64 | 379.92 | 0.00 |
substantia nigra, adult, donor10252 | 10158-103A5 |
242.39 | 211.65 | 2.08 |
substantia nigra, adult, donor10258 | 10371-105G2 |
216.73 | 110.17 | 0.52 |
substantia nigra, newborn, donor10223 | 10358-105E7 |
225.40 | 101.04 | 2.12 |
synovial sarcoma cell line:HS-SY-II | 10441-106E9 |
294.84 | 318.68 | 3.21 |
temporal lobe, adult, pool1 | 10031-101E4 |
193.36 | 110.37 | 0.68 |
temporal lobe, fetal, donor1, tech_rep1 | 10063-101H9 |
504.29 | 241.46 | 2.14 |
temporal lobe, fetal, donor1, tech_rep2 | 10063-101H9 |
351.63 | 172.30 | 1.32 |
tenocyte, donor1 | 11763-123H8 |
156.40 | 119.04 | 0.00 |
tenocyte, donor2 | 11765-123I1 |
109.87 | 109.87 | 0.00 |
tenocyte, donor3 | 11768-123I4 |
127.88 | 86.36 | 0.00 |
teratocarcinoma cell line:NCC-IT-A3 | 10790-110H7 |
503.59 | 243.72 | 0.17 |
teratocarcinoma cell line:NCR-G1 | 10798-110I6 |
370.73 | 250.64 | 2.93 |
teratocarcinoma cell line:PA-1 | 10807-111A6 |
403.41 | 240.22 | 0.62 |
testicular germ cell embryonal carcinoma cell line:ITO-II | 10786-110H3 |
365.35 | 205.15 | 1.02 |
testicular germ cell embryonal carcinoma cell line:NEC14 | 10591-108D6 |
483.68 | 302.16 | 1.89 |
testicular germ cell embryonal carcinoma cell line:NEC15 | 10593-108D8 |
395.13 | 262.40 | 1.64 |
testicular germ cell embryonal carcinoma cell line:NEC8 | 10590-108D5 |
354.36 | 276.20 | 1.30 |
testis, adult, pool1 | 10026-101D8 |
178.99 | 169.00 | 0.11 |
testis, adult, pool2 | 10096-102C6 |
273.81 | 169.16 | 0.45 |
thalamus - adult, donor10196 | 10168-103B6 |
379.77 | 195.41 | 1.10 |
thalamus, adult, donor10252 | 10154-103A1 |
249.27 | 220.83 | 1.72 |
thalamus, adult, donor10258, tech_rep1 | 10370-105G1 |
331.02 | 161.66 | 1.54 |
thalamus, adult, donor10258, tech_rep2 | 10370-105G1 |
163.87 | 83.50 | 0.16 |
thalamus, newborn, donor10223 | 10366-105F6 |
211.72 | 73.07 | 0.58 |
throat, adult | 10209-103G2 |
164.78 | 142.31 | 1.50 |
throat, fetal, donor1 | 10061-101H7 |
314.46 | 275.45 | 0.61 |
thymic carcinoma cell line:Ty-82 | 10803-111A2 |
396.67 | 174.88 | 3.97 |
thymus, adult, pool1 | 10027-101D9 |
395.27 | 389.41 | 0.60 |
thymus, fetal, pool1 | 10043-101F7 |
338.21 | 315.45 | 1.77 |
thyroid carcinoma cell line:KHM-5M | 10776-110G2 |
304.08 | 169.39 | 0.53 |
thyroid carcinoma cell line:TCO-1 | 10783-110G9 |
308.86 | 177.69 | 1.40 |
thyroid, adult, pool1 | 10028-101E1 |
175.15 | 204.82 | 0.19 |
thyroid, fetal, donor1 | 10060-101H6 |
311.65 | 212.25 | 0.79 |
tongue epidermis (fungiform papillae), donor1 | 10288-104F9 |
323.36 | 98.55 | 3.08 |
tongue, adult | 10203-103F5 |
202.34 | 118.61 | 0.70 |
tongue, fetal, donor1 | 10059-101H5 |
292.81 | 232.51 | 0.00 |
tonsil, adult, pool1 | 10047-101G2 |
234.81 | 226.40 | 0.90 |
trachea, adult, pool1 | 10029-101E2 |
155.91 | 147.32 | 0.57 |
trachea, fetal, donor1 | 10058-101H4 |
251.97 | 210.04 | 0.38 |
transitional cell carcinoma cell line:Hs 769.T | 10707-109H5 |
275.27 | 126.83 | 0.71 |
transitional-cell carcinoma cell line:5637 | 10418-106C4 |
288.55 | 215.30 | 0.51 |
transitional-cell carcinoma cell line:JMSU1 | 10492-107B6 |
311.18 | 286.42 | 1.72 |
tridermal teratoma cell line:HGRT | 10694-109G1 |
294.89 | 108.44 | 0.00 |
tubular adenocarcinoma cell line:SUIT-2 | 10797-110I5 |
242.78 | 208.75 | 0.25 |
umbilical cord, fetal, donor1 | 10057-101H3 |
194.04 | 169.01 | 0.00 |
uterus, adult, pool1 | 10100-102D1 |
167.05 | 163.29 | 0.51 |
uterus, fetal, donor1 | 10055-101H1 |
376.27 | 251.87 | 0.00 |
vagina, adult | 10204-103F6 |
169.95 | 91.11 | 0.65 |
vein, adult | 10191-103E2 |
233.01 | 144.67 | 1.10 |
xeroderma pigentosum b cell line:XPL 17 | 10563-108A5 |
169.03 | 131.65 | 0.27 |